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SUMMARY
This study is the first of its kind to highlight the importance of using the latest state of
the art technology available in the field of proteomics as a complementary tool to
characterize the proteome of members of the M ycobact eri um t ubercul osi s Beijing
lineage which have been linked to outbreaks and drug resistance of Tuberculosis
(TB).
Our label-free comparative analysis of two closely related M. t ubercul osi s strains with
different transmission patterns and levels of virulence highlighted numerous factors
that may alter metabolic pathways leading to hyper-virulence whereby the strain was
able to rapidly replicate in the host and cause extensive disease. This comparative
analysis clearly demonstrated that both instrumentation and analysis software impacts
on the number of proteins identified and thereby the interpretation of the proteomic
data. These proteomes also served as substrates for the discovery of phosphorylation
sites, a field of research that reflects a significant knowledge gap in the field of M.
t ubercul osi s . By using differential separation techniques in combination with the
state of the art mass spectrometry we described the phosphorylation sites on 286
proteins. This was the first study to document phosphorylation of tyrosine residues in
M. t ubercul osi s . By this means, our data set further extend and complement previous
knowledge regarding phosphorylated peptides and phosphorylation sites in M.
t ubercul osi s.
Using advanced mass spectrometry methods we further investigated the impact of the
i n vi vo evolution of rifampicin resistance on the proteome of a rifampicin-resistant
strain containing a S531L rpoB mutation. We identified the presence of over-
abundant proteins which could provide novel insight into potential compensatory
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mechanisms that the bacillus uses to reduce susceptibility to anti-TB drugs.  Our
findings suggest that proteins involved in a stress response may relate to an altered
physiology enabling the pathogen to tolerate and persist when exposed to anti-TB
drugs. Together this suggests that structural changes in the RNA polymerase
precipitated a cascade of events leading to alterations of metabolic pathways. In
addition, we present the first comprehensive analysis of the effect of rifampicin on the
proteome of a rifampicin resistant M. t ubercul osi s isolate suggesting that rifampicin
continues to influence the biology of M. t ub ercul osi s despite the presence of an rpoB
mutation.  Our analysis showed alterations in the cell envelope composition and
allowing the bacterium to survive in a metabolically dormant/persistent growth state.
The results presented in this study illustrate the full potential of using a proteomic
approach as a complementary molecular technique to select promising candidate
molecules and genes for further characterization using the tools of molecular biology.
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OPSOMMING
Die huidige studie is ‘n eerste van sy soort, deur die nuutste gevorderde tegnologie in
die proteomika veld te gebruik. Die proteoom van lede van die Mycobact eri um
t ubercul osi s Beijing stam, wat die oorsaak is van tuberkulose (TB) uitbrake en ook
weerstandige TB, is gekarakteriseer.
Ons merkervrye vergelykende analise van twee naby verwante M. t ubercul osi s
stamme met verskillende vlakke van oordraagbaarheid en virulensie, beklemtoon
verskeie faktore wat metaboliese paaie mag verander, wat kan ly tot hiper-virulensie,
wat die TB-stam in staat stel om vinniger te repliseer in die gasheer en ‘n uitgebreide
siektetoestand kan veroorsaak. Die analise het duidelik gewys dat die toerusting wat
gebruik word, sowel as die sagteware ‘n invloed kan hê op die hoeveelheid proteïne
wat geïdentifiseer kan word en daardeur intrepretasie van proteomika data kan
beïnvloed. Hierdie proteome dien as substrate vir die ondekking van fosforilasie
setels, ‘n veld van navorsing wat dui op ‘n gaping in ons kennis van M. t ubercul osi s .
Deur gebruik te maak van differensiële skeidingstegnieke en moderne spektrometrie
beskryf ons fosforileringsetels in 286 proteine.  Hierdie is die eerste studie wat
fosforilasie van tirosien residue in M. t ubercul osi s beskryf.  Hierdeur komplimenteer
en brei ons data die huidige kennis oor gefosforileerde peptiede en fosforilasie setels
in M. t ubercul osi s uit.
Deur gebruik te maak van gevorderde massa spektrometriese tegnieke het ons verder
ook die impak van i n vi vo evolusie van rifampicin weerstandigheid op die proteoom
van ‘n rifampicin weerstandige TB-stam met die algemene S531L rp oB mutasie
ondersoek. Ons het proteïne geïdentifiseer wat in groot hoeveelhede voorkom en kan
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nuwe insigte gee tot potensiele kompenserende meganismes wat deur die bacillus
gebruik word om vatbaarheid vir anti-TB middels te verminder. Ons bevindings dui
daarop dat proteïene betrokke in ‘n stresreaksie mag lei tot ‘n verandering in fisologie
wat die patogeen in staat stel om anti-TB middels te verdra en te volhard in die
teenwoordigheid van sulke middels.  Saam impliseer dit dat ‘n ketting van gebeure
wat lei tot veranderinge in metaboliese paaie, word vooraf gegaan deur strukturele
veranderinge in die RNS polimerase.  Tesame hiermee bied ons ook die eerste
omvattende analise aan van die effek wat rifampicin op die proteoom van ‘n
rifampicin weerstandige M. t ubercul osi s isolaat het, en wat aan die hand doen dat
rifampicin voordurend die biologie van M . t uber cul osi s beïnvloed, ten spyte van die
teenwoordigheid van ‘n rpoB mutasie. Ons analise dui op veranderinge in die
samestelling van die selomhulsel wat die bakterie toelaat om te oorleef in ‘n
metabolies dormante staat.
Die resultate wat in hierdie studie aangebied word illustreer die volle potensiaal van
‘n proteomiese benadering as komplementêre molekulêre tegniek om belowende
kandidaat molekules en gene te kies vir verdere karakterisering, deur gebruik te maak
van molekulêre tegnieke.
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1CHAPTER 1
INTRODUCTION
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2Background
The pathogen M ycobact eri um t ubercul osi s (M. t ubercul osi s ), the causative agent of
tuberculosis (TB), remains a global public health concern. According to the World
Health Organisation (WHO) it is estimated that approximately 2 million people die
from TB per year, while 9 million new cases develop (“WHO | Global tuberculosis
control 2011,” 2012).  This places an enormous burden on the South African National
TB Control Programme since they are required to diagnose an estimated 540,000
cases of TB every year. This is further constrained by the fact that 70 % of the TB
treatment budget is allocated to the treatment of multi-drug resistance TB (MDR).
A major landmark in the history of TB research was the deciphering of the M.
t ubercul osi s genome sequence which has provided a blue print for research into the
physiology of this pathogen with the goal of developing new drugs, diagnostics and
vaccines (Cole et  al ., 1998; Starck et  al ., 2004). Molecular epidemiological studies
have shown that the current epidemic is driven by numerous different genotypes and
that most TB patients develop disease through recent infection (transmission) (Van
der Spuy et  al ., 2009).  Furthermore, patients are at risk of reinfection either before or
after developing disease, suggesting an extremely high infection pressure in high
burden settings.  The frequency at which the different M. t ubercul osi s genotypes
appear in different settings suggests the evolution of different pathogenic
characteristics (Van der Spuy et al., 2009).  Recently, animal studies have shown that
certain sub-types of the M. t ubercul osi s Beijing strains are more virulent than others
(Parwati et  al ., 2010), further emphasising the idea that not all strains (or sub-strains)
possess the same virulence characteristics.  However, the mechanisms underlying
these differences remain to be elucidated.  Comparative genomics suggest that the
genome of M.  t ubercul osi s has evolved through single nucleotide polymorphisms
Stellenbosch University  http://scholar.sun.ac.za
3(SNP’s), insertions and deletions (Filliol et  al ., 2006).  Despite an ever increasing
number of genomes being sequenced the mechanisms defining pathogenesis remain
largely unknown. Furthermore, our knowledge of how mutations may impact on
structural changes and protein function, regulatory mechanisms or Post Translational
Modifications (PTM’s) remains largely unknown. Studies of these changes could be
crucial in predicting the function of specific proteins involved in virulence and the
design of new anti-tubercular vaccines and drugs.  Protein phosphorylation, one of the
most studied PTM’s, could provide a lead in identifying the cause of phenotypic
differences of genetically similar clinical M. t ubercul osi s strains. Protein
phosphorylation is involved in the regulation of numerous essential biological
processes described in both prokaryotes and eukaryotes and it is speculated that
perturbations in the equilibrium of bacterial kinases and phosphatases may be
involved in infectious diseases.  In order to understand the biology and pathogenic
mechanisms of M. t ub ercul osi s it is relevant to establish which proteins are
phosphorylated at a whole proteome level.  Characterising and identifying
phosphorylated proteins is a challenging analytical task due to the low abundance and
stoichiometry of phosphopeptides/proteins in complex protein samples and the
presence of active phosphatases in the cells lysed during protein extractions (Oda et
al ., 2001).  Thus, we have optimised a recently developed method using combining
strong cation exchange (SCX) with titanium dioxide (TiO2) to enrich for
phosphorylated peptides (Wiśniewski et  al ., 2010; Nagaraj et  al ., 2012) in a complex
M. t ubercul osi s protein sample.
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4The use of proteomics as a complementary molecular tool is not only important for
defining the biology of drug sensitive TB but is also essential for understanding the
persistence and successful spread of drug resistant strains.  Classical dogma has
incorrectly assumed that the acquisition of resistance compromised fitness and thus
transmissibility (Cohen e t  al ., 2003).  This dogma has been challenged by molecular
epidemiological studies which have clearly demonstrated that drug resistant strains
are actively transmitted and that the drug resistance epidemic is driven by
transmission (Cohen et  a l ., 2003). In vi t ro studies analysing spontaneously generated
drug resistant TB mutants have shown a direct correlation between mutations in a
specific target gene and resistance to the anti-TB drug used to select the resistant
mutants (Meier et  al ., 1996).  Consequently, the relationship between a defined
mutation and resistance to a specific anti-TB drug has become a dogma and now
forms the basis for the development of molecular-based drug-resistance diagnostic
assays (Ramaswamy and Musser, 1998; Johnson et  al . , 2006).  However, the above
studies have failed to exclude the possibility that additional modulatory mutations
may occur concurrently in association with the evolution of drug-resistance.  This
hypothesis is supported by molecular epidemiological studies and i n vi t ro velocity
assays which provide evidence to suggest that compensatory mutations may
ameliorate the fitness cost associated with acquisition of drug resistance (Comas et
al ., 2011). This has lead scientists to focus their research efforts on the discovery of
compensatory mutations which may explain restoration of fitness and transmissibility
of drug resistant M. t uber cul osi s strains (Comas et  al ., 2011).
The accumulation of mutations occurring during the evolution of drug resistance may
be more complex than only restoring fitness as these mutations may be associated
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5with an altered physiology.  This is supported by the observation that the level of
Rifampicin (RIF) resistance (as measured by the Minimum Inhibitory Concentration
(MIC)) was highly variable among isolates with the same genetic background and
identical mutation conferring resistance to RIF (Louw et  al ., 2011).  However, the
genetic and/or proteomic basis of these phenotypes remain unknown.  Our limited
knowledge of the physiology of drug resistant TB can partly be ascribed to current
dogma (one mutation one resistance phenotype), which polarised scientific thinking
that drug resistant strains are physiologically identical to drug sensitive strains with
the exception of the drug resistance mutations.  Thus, the interplay between
antibiotics/metabolic inhibitors and gene expression is limited to studies on drug
sensitive strains of M. t ubercu l osi s .  We do not know how drug resistant strains
respond to the drugs to which they are resistant.  The importance of this is
underscored by the fact that all patients diagnosed with TB are placed onto a standard
treatment regimen until the time that either treatment failure or drug susceptibility
testing suggests the need for an alternative regimen.
Over the last decade the tremendous advances in proteomics now provide the
opportunity to identify proteins involved in novel pathways which is associated with
virulence, transmissibility and resistance to antibiotics. By using a novel proteomic
approach we showed an over-abundance of cell wall proteins as well as regulatory
proteins in a highly-transmissible strain as compared to a non-transmitted strain (de
Souza et  al ., 2010).  Using a proteomics approach may enable the identification of
compensatory mechanisms that the mycobacterium develops in response to
antibiotics. Thus, if drug resistant strains demonstrate a unique physiology it is
conceivable that this physiology influences the propensity of a given drug resistant
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6strain to develop resistance to specific additional drugs or to adapt in a manner which
induces cross-resistance to subsequent treatment.
Hypothesis: The phenotype of a M . t ubercul osi s strain is defined by changes in the
proteome as a result of altered gene expression which may or may not be derived from
genomic mutation.
Overall aim: To determine the proteomes of different clinical M . t ubercul o si s isolates
which demonstrate different phenotypes (virulence and drug resistance).
Ethical approval: Ethical approval for the above projects has been granted by the
Faculty of Medicine and Health Sciences under the project titles:
1. Characterisation of the Mycobacterium tuberculosis phosphorylome and its
role in pathogenesis (N06/10/204).
2. An investigation into the evolutionary history and biological characteristics of
the members of the genus Mycoba ct eri um , with specific focus on the different
strains of Mycobact eri u m t ubercul osi s , other members of the M. t ubercul osi s
complex and non-tuberculous mycobacteria (NTM) (92/008, 96/093,
2000/c056, 2000/C061, 2002/C118, N04/08/135).
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Literature review
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All biological and physiological processes are directly or indirectly regulated by
protein phosphorylation, a signal transduction cascade which links the external- to the
internal cellular environment (Kobir et  al ., 2011).  This process is considered to be the
most important known reversible PTM found in nature, and is involved in multiple
cellular processes ranging from metabolism and homeostasis to cellular signaling
(Graves and Krebs, 1999).  Protein phosphorylation relies on amino acid specific
protein kinases which phosphorylate the free hydroxyl group of serine, threonine and
tyrosine (Cozzone, 1998).  The protein thereby gains a γ-phosphoester residue at the
expense of adenosine triphosphate (ATP) which acts as the phosphoryl donor. A non-
phosphorylated protein can be phosphorylated at multiple sites by the same kinase in
a metabolic pathway or kinases belonging to different pathways (Fiuza et  al ., 2008).
The phosphorylation of a single protein at multiple sites increases the extent to which
its activity can be regulated (Graves and Krebs, 1999). Phosphorylation is also
coupled to the reverse reaction (dephosphorylation) which is mediated by protein
phosphatases.  These enzymes catalyze the reaction whereby the phosphate is
removed from the phosphorylated protein (Graves and Krebs, 1999).  This restoration
of the dephosphorylated state, and vi c e v ersa (Hunter, 1995), is capable of rapid and
efficient activation or inactivation of candidate proteins and their subsequent
functions. This cascade represents a bidirectional and reusable molecular “on/off”
switch (Cohen, 2002).
Although protein phosphorylation has been extensively investigated in eukaryotes, it
was only discovered in prokaryotes in the late 1970’s (Garnak and Reeves, 1979a,
1979b; Manai and Cozzone, 1979).  In prokaryotes, 9 amino acids have been found to
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9be phosphorylated and include; serine, threonine, tyrosine, histidine, lysine, arginine,
aspartate, glutamate, and cysteine (Klumpp et  al ., 2002).
It is now well recognised that protein phosphorylation is a key process in the
regulation of cell homeostasis which has been implicated in disease and pathogenesis
(Tan et  al ., 2009).  As such, phosphoproteomics have become a major focus in the
research of infectious diseases.  To date, the phosphoproteomes of 9 pathogenic
bacteria (Mijakovic and Macek, 2012), including M ycobact eri um t uber cul osi s (M.
t ubercul osi s ) H37Rv have been described and summarized in table 2.1.
Table 2.1: Published phosphorylomes of pathogenic bacteria
Pathogenic bacteria # Proteins # Phosphosites Reference
Corynebacterium g lu ta mic u m 78 103 (Bendt e t a l ., 2003)
Ca mp y lo b a c te r je ju n i 36 0 (Voisin e t a l ., 2007)
B a c illu s su b tilis 78 78 (Macek e t a l ., 2007)
Kle b sie lla  p n e u mo n ia 81 93 (Lin e t a l ., 2009)
P se u d o mo n a s a ru g in o sa 57 55 (Ravichandran e t a l ., 2009)
P se u d o mo n a s p u tid a 56 53 (Ravichandran e t a l ., 2009)
S tre p to c o c c u s p n eu mo n ia 84 163 (Sun e t a l ., 2010)
My c o p la sma  p n e u mon ia 63 16 (Schmidl e t a l ., 2010)
My c o b a c te riu m tu b e rc u lo sis 301 516 (Prisic e t a l ., 2010)
Mycobacterium tuberculosis
Unravelling the M. t ub ercul osi s genome sequence has provided a blue print for
research into the physiology of this pathogen with the goal of developing new drugs,
diagnostics and vaccines (Cole et  al ., 1998; Starck et  al ., 2004). According to
Tuberculist (http://tuberculist.epfl.ch/) a total of 4018 open reading frames (ORFs)
were identified in the genome and these were grouped in 12 functional categories
(Cole et  al ., 1998). Previous studies using monoclonal antibodies showed that
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‘eukaryotic-like’ protein phosphorylation occurs in the pathogen, M. t ubercul osi s
(Chow et  al ., 1994).  Furthermore, the use of molecular techniques such as Southern
Blot analysis, PCR and whole genome sequencing demonstrated that M. t ubercul osi s
encodes 11 ‘eukaryotic-like’ protein kinases (Av-Gay and Everett, 2000) as well as 11
complete two-component regulatory systems (Stock et  al ., 2000). The existence of
these ‘eukaryotic-like’ Ser/Thr protein kinases (STPK) genes in the M. t ubercul osi s
genome indicates that protein phosphorylation plays a central role in regulating
various biological functions, ranging from adaptative responses to bacterial
pathogenicity (Av-Gay and Everett, 2000; Ravichandran et  al ., 2009).
M. tuberculosis STPKs and their substrates
STPKs are single transmembrane receptors, which can be autophosphorylated at the
serine- and threonine residues on the intracellular domains of the receptor.  STPKs’
are known to act as sensors of the external environment, which in turn signal to the
intracellular environment allowing for regulation of developmental changes and host
pathogen interactions (Tyagi and Sharma, 2004) .
In an attempt to classify the mycobacterial STPKs’, a phylogenetic tree was generated
by analysing the full length gene sequences of the 11 STPKs’ from 6 completely
sequenced mycobacterial genomes (Narayan e t  al ., 2007).  This phylogenetic
construction grouped the STPK’s into 5 clades (Table 2.2).
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Table 2.2: Summary of STPK’s identified in M. tuberculosis
Rv number Gene name Substrate Function Clade Reference
Rv0015c p k n A GroEL1, KasB, Wag31 Heat shock, Mycolic acid biosynthesisCell divison
I (Chaba e t a l ., 2002)
Rv0014c p k n B GarA,KasB, Rv0020c,Rv1422, Rv1747, Wag31
Glycogen recycling, Tricarboxylic acid cycle, Mycolic
biosynthesis, FHA-containing protein, Putative ABC
transporter, Cell division
I (Av-Gay e t a l ., 1999; Young e t
a l ., 2003)
Rv0931c p k n D GarA, GroEL1, Rv1747,Rv0516c, Mmpl7
Glycogen recycling, Tricarboxylic acid cycle, Heat shock
protein, Putative ABC transporter
II (Peirs et al., 1997; Greenstein,
Echols, et al., 2007)
Rv1743 p k n E GarA, GroEL1, KasB,Rv1747
Glycogen recycling, Tricarboxylic acid cycle, Mycolic
biosynthesis, Heat shock protein, Putative ABC
transporter
II (Molle e t a l ., 2008)
Rv1746 p k n F GarA, GroEL1, KasB,Rv0020c, Rv1747
Glycogen recycling, Tricarboxylic acid cycle, Mycolic
biosynthesis,  FHA-containing protein,Putative ABC
transporter
III (Koul e t a l ., 2001; Molle e t a l .,
2008)
Rv0410c p k n G GarA Glycogen recycling, Tricarboxylic acid cycle
V (Koul et al., 2001; Fiuza et al.,
2008)
Rv1266c p k n H embR Tricarboxylic acid cycle
II (Sharma e t a l ., 2006)
Rv2914c p k n I EmbR/EmbR2 Phosphotransferase, Tricarboxylic acid cycle, Glycanbiosynthesis and metabolism
III (Narayan e t a l ., 2007)
Rv2088 p k n J MyBP Tricarboxylic acid cycle, Glycan biosynthesis and
metabolism, Integral membrane protein
III (Arora e t a l ., 2010)
Rv3080c p k n K virS Phosphotrasferase, Tricarboxylic acid cycleGlycan biosynthesis and metabolism
IV (Kumar e t a l ., 2009)
Rv2176 p k n L GroEL1, KasBRv2175 Heat shock Protein, Mycolic acid biosynthesis
I (Canova e t a l ., 2008)
Stellenbosch University  http://scholar.sun.ac.za
12
PknA , P knB , P knD , P kn E , PknF , PknH , Pkn I , Pk nJ , PknL are predicted to be transmembrane
receptors (Narayan et  al ., 2007) which are hypothesised to be involved in growth, stress
responses and host-pathogen interactions (Grundner, Gay, et  al ., 2005).  The genes pkn G and
pknK code for soluble protein kinases with no apparent transmembrane regions (Av-Gay and
Everett, 2000).
Using transposon mutagenesis, pknA , pkn B and pknG were shown to be genes essential for
the growth of M. t ub erc ul osi s in culture (Sassetti and Rubin, 2003; Sassetti et  al ., 2003).
PknA, pknB are pst P are part of an operon which encodes genes involved in cell shape control
and cell wall synthesis (Av-Gay and Everett, 2000; Fernandez et  al ., 2006; Wehenkel et  al .,
2008).  Both pknA  a nd pknB are expressed during exponential growth, while their over
expression slows growth and alters cell morphology (Kang, 2005).  Expression of pknB and
pst P is upregulated during exponential growth or infection (Boitel et  al ., 2003), while pknB is
down regulated during nutrient starvation (Betts et  al ., 2000).  This demonstrates their
imperative influence in the survival of M. t ub er cul osi s during infection.  Recently it was
shown that the pseudokinase and transmembrane protein MviN is a substrate for PknB and is
involved in peptidoglycan synthesis in M. t ubercu l osi s (Gee et  al ., 2012).
PknD alters transcription of an anti-anti-sigma factor homolog, Rv0516c which is specifically
phosphorylated at a novel site, Thr2 (Greenstein, MacGurn, et  al ., 2007) upon its over
expression.  This residue is a conserved ser/thr phosphorylation site in the anti-anti-sigma
factor family (Greenstein, MacGurn, et  al ., 2007). PknD specific activity induces a
transcriptional response leading to an abnormal phosphorylation of physiological changes
that is sensitive to alterations in the activity of regulatory factors other than kinases
(Greenstein, Echols, et al . , 2007).
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It has been shown that the autophosphorylated form of PknF leads to an interaction with and
phosphorylation of the ABC transporter (Rv1747).  The p knF and Rv1747 genes are
adjacently located on the M. t ubercul osi s genome to form an operon. Rv1747 has been
implicated in the transport of glucose across the membrane and is required for virulent M.
t ubercul osi s infection in mice (Curry et  al ., 2005). Rv1747 contain 2 of the 7 Forkhead-
associated (FHA) domains encoded by the 6 FHA domain containing proteins in the M.
t ubercul osi s genome.  FHA domains are phosphopeptide recognition motifs spanning 80-100
amino acid residues which are folded in an 11-stranded beta sandwich (Spivey et  al ., 2011).
The FHA domain mediates phosphopeptide interactions with proteins which have been
phosphorylated by STPKs (Grundner, Gay, et  al ., 2005).  The majority of FHA domains
recognize phospho-threonine (Durocher et  al ., 2000), with specificity for residues at the C-
terminal of the phospho-threonine site, particularly the +3 position.  PknF binds to the
phosphorylated sites at Thr-150 and Thr-208 of Rv1747 where it exhibits ATPase activity
allowing the uptake of glucose by the ABC transporter (Spivey et  al ., 2011).
The physiological role of mycobacterial PknG remains unclear, however, it is hypothesised
that PknG is involved in the survival of M.  t ubercul osi s inside the macrophages and is a
sensor for nutritional stress (Cowley et  al ., 2004).  In addition, this cytosolic protein can be
secreted into the macrophage providing further evidence of its important role in infection
(Cowley et  al ., 2004).  Autophosphorylation of PknG in the thioredoxin (Trx) domain is
crucial for the survival of M. t ubercu l osi s within the infected macrophage (Walburger et  al .,
2004; Scherr et  al ., 2009).
It has been shown that PknE has been implicated in intracellular survival of M. t ubercul osi s
by suppressing apoptosis (Kumar and Narayanan, 2012).  It is suggested that PknE could play
an important role in sensing various environmental changes, in particular during infection of
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the macrophages and possible activate multiple signalling processes allowing physiological
adaptation in order for its survival (Kumar and Narayanan, 2012).
The PknH gene is located adjacent to the EmbR transcriptional regulator in the M.
t ubercul osi s genome.  Phosphorylation of EmbR enhances binding to the embCAB
arabinisyltransferase promoter leading to increased transcription of these enzymes.  PknH
functions as a feedback regulator, altering the production of cell wall constituents in response
to environmental signals.  However it has been shown that the sensor domain of PknH may
regulate the cell-wall production in response to environmental cues, such as compounds that
are not related to the mycobacterial cell wall (Cavazos et  al ., 2012).
Based on transposon mutagenesis studies PknL was found to be non-essential for in vitro
growth of both M. t ubercul osi s H37Rv and CDC1551.  However subtle regulatory functions
brought about by protein interactions with Rv2175c were observed (Canova et  al ., 2008).
PknK is involved in the regulation of growth whereby it regulates tRNA expression during
logarithmic and stationary growth phases as a means to facilitate adaptation to changing
environments (Molhotra, 2012).  It has been demonstrated that PknK-mediated
phosphorylation increases the affinity of the transcriptional regulator, VirS for the my m
(mycobacterial monooxygenase) promoter and stimulates its transcription under acidic
conditions (Kumar et  al ., 2009).
PknI appears to be required for balanced growth of M. t ubercul osi s inside macrophages and
under the i n vi t ro conditions which are used to mimic growth inside macrophages.  PknI
plays a pivotal role in controlling the growth of M. t ubercul osi s upon infection by slowing
down the growth once inside the host macrophage.  Internal signals used to activate PknI are
most likely the host associated internal signals of low pH associated with limited oxygen
availability (Gopalaswamy et  al ., 2009).
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M. tuberculosis phosphatases and their substrates
Even though a large number of protein kinases involved in the regulatory processes of M .
t ubercul osi s have been recognised, the number and variety of phosphatases has only recently
been discovered (Cohen, 1997).  The presence of two ‘eukaryotic-like’ phosphatases suggests
that M. t ubercul osi s might utilise ‘eukaryotic-like’ signalling as alternative signalling
transduction pathways (Boitel et  al ., 2003).  ‘Eukaryotic-like’ Ser/Thr phosphatases (PstP)
can be divided into two families which are categorised according to their sequence
similarities, metal-ion-dependence and sensitivity to inhibitors (Barford et  al ., 1998); protein
phosphatase P (PPP) (Bellinzoni et  al ., 2007) and metal-dependent protein phosphatases
(PPM) (Rigden, 2011). PstP has been identified as a metalloenzyme belonging to the PPM
family of Ser/Thr protein phosphatases and has been found to dephosphorylate various
mycobacterial STPKs’ and their substrates (Boitel et  al ., 2003; Chopra et  al ., 2003).  In
addition, Boitel and co-workers provided evidence that phosphorylated PknB served as a
substrate for the Ser/Thr phosphatase (PstP) (Boitel et  al ., 2003).
Tyrosine Phosphorylation in M. tuberculosis
The protein-tyrosine kinases (PTK) and phosphatases (PTP) found in bacteria are structurally
and functionally similar to those found in eukaryotes (Cozzone et  al ., 2004).  The ability to
reverse tyrosine phosphorylation is dependent on two putative protein-tyrosine phosphatases
(PTP), PtpA and PtpB (Shi et  al ., 1998; Greenstein et  al ., 2005).  According to Cole (Cole et
al ., 1998), the M. t uber cul osi s genome encodes for both protein tyrosine phosphatase A
(PtpA) and protein tyrosine phosphatase B (PtpB) however, to date only one tyrosine kinases,
(encoded by R v223 2 ; pt k A ) has been identified in M. t uber cul osi s (Cowley e t  al ., 2002).  It
has been suggested tyrosine phosphatases are secreted into the host, where they target
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components of the host signalling pathway.  As such, PtpA has been identified as a novel
drug target and has been investigated as efficient inhibitors of PtpA (Chiaradia et  al ., 2008).
Recently, Av-Gay and colleagues identified PtkA, a novel PTK that acts as substrate for
mycobacterial PtpA (Bach et  al ., 2009).  PtkA has been shown to phosphorylate two tyrosine
residues (Tyr128 and Tyr129) located in PtpA.  Furthermore, that study showed that the
presence of a phosphate donor, i.e. ATP or GTP, increased the interaction between PtkA and
PtpA (Bach et  al ., 2009). The function of PtpA remains unclear, although evidence suggests
that it plays a role in the manipulation of the host response during M. t ub ercul osi s infection
(Tyagi and Sharma, 2004; Jers et  al ., 2008).
Recent studies have shown that the M.  t ubercul osi s phosphatase, PtpB, is not amino acid
specific but does exhibit dual specificity, implying that this enzyme can dephosphorylate
proteins which have been phosphorylated on either serine or threonine residues (Greenstein et
al ., 2005). M. t ubercul osi s PtpB is routinely detected in both culture filtrates and whole cell
lysates, which suggests that it is secreted into the extracellular medium (Grundner, et  al .,
2005).  Interestingly, a recent study by Beresford and colleagues showed that PtpB also
dephosphorylates phosphoinositides (Beresford et  al ., 2007).  In the host cells
phosphoinositides are involved in membrane trafficking, actin remodeling and cell survival
(Grundner, et  al ., 2005).  Secretion of an effector protein by the pathogen which may directly
interact with these host phosphoinositides would result in the destabilization of the
phosphoinositide metabolism (Silva and Tabernero, 2010).  In addition, PtpB has been
suggested to play an important role in the regulation of growth, development and
pathogenesis of M. t uber cul osi s (Beresford et  al ., 2010). Furthermore, it was observed that
the PTPs’, PtpA and PtpB are secreted into the host cells and function as virulence factors
(Koul et  al ., 2000, 2000; Cozzone et  al ., 2004).
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Two component system in M. tuberculosis
Prokaryotic signal transduction generally relies on the reversible protein phosphorylation
conducted by two component systems (Stock et  al ., 2000).  This process of
phosphorylation/dephosphorylation leads to an alteration of the proteins inherent biological
activity leading to a biochemical or cellular component change (Xing et  al ., 2002) and
important in the adaptive regulation of the bacteria due to environmental change or stress
(Bagchi et  al ., 2005).  The molecular system responsible for stimulus response in bacteria
involves the so called two component system of histidine kinase sensor and associated
response regulators.  The two component signal transduction involves a signalling histidine
kinase (HK) and an effector response regulator (RR).  Here, the HK is regulated by an
environmental stimuli and autophosphorylates at a histidine residue.  This in effect creates a
high energy phosphoryl group that is transferred to an aspartate residue in the RR.  This
response, in combination with the DNA-binding activity regulating gene expression
(Shrivastava et  al ., 2007).  Transcriptional regulatory studies of five of the mycobacterial
two-component systems including devS-devR, senX3-regX3, trcR-trcS, prrA-prrB and mprA,
indicates their involvement in auto-regulation where the histidine kinase phosphorylates the
conserved histidine residue in the kinase domain (Haydel et  al ., 1999; Himpens et  al ., 2000;
Ewann et  al ., 2004; He and Zahrt, 2005).  The involvement of the remaining 7 two-
component systems in pathogenesis and virulence remain to be investigated.  To date only
one of the 11 two-component systems MtrA/MtrB in M. t ubercul osi s was shown to be
essential for growth (Zahrt and Deretic, 2000).
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Table 2.3: Two-component systems of M. tuberculosis identified and characterised
Rv numbers Two-component systems References
Rv3245c/Rv3246c MtrB-MtrA (Zahrt and Deretic, 2000)
Rv1032c/Rv1033c TrcS/TrcR (Haydel e t a l ., 1999)
Rv3132c/Rv3133c DevS-DevR (Saini e t a l ., 2004)
Rv0902c/Rv0903c PrrB/PrrA (Ewann e t a l ., 2004)
Rv0757/Rv0758 PhoP/PhoR (Zahrt and Deretic, 2000)
Rv0844c/Rv0845c NarL/NarS (Tyagi and Sharma, 2004)
Rv0981/Rv0982 MprA/MprB (Zahrt e t a l ., 2003)
Rv1027c/Rv1028c KdpE/KdpD (Parish, Smith, Roberts, e t a l ., 2003)
Rv3764c/Rv3765c TcrY/TcrX (Parish, Smith, Roberts, e t a l ., 2003)
Rv1626/Rv3220c PdtaR/PdtaS (Morth e t a l ., 2005)
Rv0490/Rv0491 SenX3/RegX3 (Himpens e t a l ., 2000)
The PdtaR/PdtaS two-component system was first described by Morth et  al . (Morth et  al .,
2005).  PdtaR acts as a transcriptional anti-termination rather than a transcriptional initiator
while the PdtaS is localised in the cytosol and is constitutively active i n vi t ro (Morth et  al .,
2005). PdtaS contains sensing modules; cGMP-regulated cyclic nucleotide
phosphodiesterases, adenylyl cyclases and the bacterial transcription factor FhlA (GAF) and a
Per-ARNT-SiM (Drosophila Period,-Arylhydrocarbon Receptor Nuclear Transport and
Drosophila Single-Minded (PAS) domains).  Preu and colleagues demonstrated that the
PdtaR/PdtaS two-component system is structurally similar to and has a similar function as the
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EutW/EutV two-component system that is involved in the regulation of ethanolamine
catabolism in gram positive-bacteria (Preu et  al ., 2012).
The two-component system MtrA/MtrB, was initially investigated in C . gl ut ami cum (Möker
et  al ., 2004).  In M. t uber cul osi s MtrA/MtrB is involved in osmoregulation and the control of
cell wall metabolism (Bott and Brocker, 2012) and has been shown to be essential (Zahrt and
Deretic, 2000).  The response regulator MtrA has been identified in the sera of TB patients
indicating the involvement of MtrB/MtrA two-component system in pathogenesis (Singh
2001).  The PhoP/PhoR two-component system has been implicated in virulence based on the
observation that the Pho P gene is required during intracellular growth but not essential for
persistence of the bacilli in the macrophages (Pérez et  al ., 2001).
The DevR-DevS, two-component systems in M. t ubercul osi s has been characterised and
described in detail (Dasgupta et  al ., 2000).  The DevR-DevS forms part of the DosR-regulon
which is activated by hypoxic conditions and regulates expression 47 genes, induced in M.
t ubercul osi s during growth under these conditions (Park, Lee, et  al ., 2003).  This two-
component system is found in BCG and M. sm egmat i s where it is required for long term
survival during hypoxia, oxygen deprivation, heat stress, tolerance, respectively (O’Toole et
al ., 2003).
The M.  t ubercul osi s PrrA-PrrB two-component system is expressed during intracellular
growth and is suggested to be important in establishing infection in human macrophages
(Haydel et  al ., 1999; Ewann et  al ., 2002).  It has recently been shown that transcription of
PrrA-PrrB was induced during nitrogen starvation and plays an important in mycobacterial
growth and metabolism (Haydel et  al ., 2012).  The M. t ubercul osi s SenX3-RegX3 two-
component system has been implicated in virulence and phosphate-responsive control of gene
expression and further alters the expression of aerobic respiration (Roberts et  al ., 2011).
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M. tuberculosis phosphoproteome
To date 516 phosphorylation events which mapped to 301 proteins have been reported in M.
t ubercul osi s (Prisic et  al ., 2010).  The authors identified a wide range of serine/threonine
phosphorylated proteins as well as previously described phosphorylated proteins including, 4
STPKs, GarA, Rv1422 and FHA thereby demonstrating the influence of the STPKs in the
regulation of various cellular processes and their impact on the regulatory mechanisms,
which may likely be involved in M. t ubercul osi s virulence (Prisic et  al ., 2010).  They further
identified a dominant motif shared by 6 M. t ubercul osi s STPKs using mot i f - x (Schwartz and
Gygi, 2005).  A bioinformatics approach was used to identify 215 specific phospho-acceptor
residues within each phosphopeptide. The dominant motifs were validated in each
phosphopeptide and lead to the identification of the +3 position relative to the phospho-
threonine residue preferred by each kinase (Prisic et  al ., 2010). According to Tuberculist
(Lew et  al ., 2011), the functional categorization of the phosphorylated proteins identified in
the H37Rv phosphorylome analysis showed that most of the proteins were involved in cell
wall and cell processes as well as intermediary metabolism and respiration (Table 2.4).
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Table 2.4: Functional categorization of phosphorylated proteins identified in H37Rv phosphorylome (Prisic et al., 2010)
Functional group number * Functional categories* Number of phosphorylated proteins
F0 Virulence, detoxification and adaptation 10
F1 Lipid metabolism 22
F2 Information pathways 25
F3 Cell wall and cell processes 68
F4 Stable RNAs 0
F5 Insertion sequences and phages 4
F6 PE/PPE families 15
F7 Intermediary metabolism and respiration 72
F8 Unknown 0
F9 Regulatory proteins 20
F10 Conserved hypothetical 65
Total number of phosphorylated proteins identified 301
*The functional groups from Tuberculist database, http://tuberculist.epfl.ch
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6. Conclusion
The identification and characterisation of putative kinase and phosphatase genes in the M.
t ubercul osi s genome suggests their participation in key biological processes such as gene
expression and cell growth.  The identification and characterisation of more substrates and
targets of protein kinases and phosphatases in M. t ubercul osi s will help with understanding
the pathogenesis and transmission of this disease causing bacteria.  Phosphoproteomics can
now be used to investigate phosphorylation as a potential avenue to alter bacterial growth and
to discover novel proteins for potential therapeutic targets. Variation in the phosphorylation
pattern may provide novel insights into regulatory pathways during various M. t ubercul osi s
growth stages.  Such information could enable the identification of pathways regulating the
latent infection as well as characterizing novel drug targets.  Unique phosphorylation patterns
for each strain or sub-type may reflect strain specific mechanisms regulating pathogenicity
and virulence. However, it must be acknowledged that the description of the
phosphoproteome is largely limited to a single publication and it is expected that many more
phosphorylated proteins are still to be discovered in M. t ubercul osi s .
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CHAPTER 3
METHODOLOGY
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The proteomes of different M. t ubercul osi s strains from and epidemiological sample bank
demonstating varying levels of virulence and drug resistance were analysed using the latest
state of the art proteomics and mass spectrometry tools. An ouline of the experimental
procedures is given in figure 3.1.
Figure 3.1: Overview of experimental study design
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3.1: Genotypic classification
M. t ubercul osi s isolates were cultured from TB patients attending primary health care clinics
in an epidemiological field site in the Western Cape, South Africa over a 12 year period
(figure 3.2A).  Positive M. t ubercul osi s cultures were genotyped by IS 6110 DNA
fingerprinting and spoligotyping according to international standards (van Embden et  al .,
1993, 1993).  The clinical isolates selected, (susceptible, rifampicin RIF-mono-resistant, and
MDR) and analysed in this thesis are from the genetically distinct Beijing lineage. The
presence of contaminants in M. t ubercul osi s cultures were continuously monitored with
plating the culture onto a blood agar for two days ( M. t ubercul osi s does not grow on blood
agar within 2 days).  Ziehl-Neelsen gram staining of M. t ubercul osi s smears were heat fixed
(heated for 2 hours at 100 °C), stained with carbol-fuchsin (Becton, Dickinson and Company,
Maryland, United States of America (USA)) and decolorized with acid alcohol for positive
identification of M. t ube rcul osi s .  The smears were then counterstained with methylene blue
(Becton, Dickson and Company, Maryland, USA) and read under the light microscope for
acid-fast bacilli. M. t ubercul osi s , an acid-fast bacterium, will retain dyes when heated and
treated with acidified organic compounds.  Therefore the bacilli will appear pink in a
contrasting background when the ZN test is done.
3.1.1. Clinical hypo- and hyper-virulent M. t ubercul osi s strains
Genotyping of M. t uberc ul osi s (figure 3.2B) from our epidemiological reference bank strain
collection identified 452 isolates with the Beijing genotype, of which 319 were classified as
members of sub-lineage 7 and were characterised by the regions of difference (RD) 150
deletion (Hanekom et  al ., 2007).  Within this sub-lineage, 288 cases were clustered into 21
transmission chains (cluster size ranged from 2 to 147), and 31 cases had unique IS6 110
DNA fingerprints. Transmission chains were defined as a series of cases having isolates with
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identical IS 6110 DNA fingerprints (Van Embden et  al ., 1993) with inter-case intervals of less
than 2 years and each transmission chain was assumed to be initiated by a single index case
(Van der Spuy et  al ., 2009).  A transmission chain unique case was defined as one having no
other cases with the identical strain occurring within 2 years (Van der Spuy et  al ., 2009).
Analysis of the population structure of M. t uber cul osi s over time revealed that the Beijing
genotype was increasing exponentially relative to the other dominant genotypes (figure 3.1A)
(Van der Spuy et  al ., 2009).  The Beijing genotype has been associated with numerous multi-
drug resistant outbreaks around the world (Lan et  al ., 2003; Cox et  al ., 2005). To determine
whether an actively transmitting strain showed different pathogenic properties to that of a
non-transmitting strain, one isolate representative of the largest cluster (n = 147 cases) and
one unique isolate were randomly selected for further analysis.  The IS 6110 DNA
fingerprints of these two strains with different transmission chains showed no significant
variation (figure. 3.2B).
The virulence (as determined by survival, lung pathology and bacterial load) of each selected
isolate was evaluated in 6 to 8 week old male BALB/c mice, in collaboration with Prof R
Hernandez-Pando, Mexico. Briefly, bacteria were grown in Middlebrook 7H9 broth (Difco,
Detroit, MI USA) enriched with glycerol and albumin, catalase and dextrose (Becton
Dickinson, Cockysville MD, USA), and incubated with constant agitation at 37°C and 5%
CO2 for 21 days.  Growth was monitored by densitometry.  As soon as the culture reached
stationary phase (OD600 =1) the bacilli were harvested, and the concentration was adjusted to
2.5 x 105 viable bacilli per 100μl of phosphate buffered saline (PBS) as determined by
diacetate fluorescein incorporation, and 100 l aliquots were frozen at -70°C until use.  To
induce progressive pulmonary TB, mice were anaesthetized with sevoflurane and inoculated
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intratracheally with 2.5 x 105 bacilli in 100 l PBS.  Infected mice were kept in a vertical
position until the effect of anaesthesia passed.
Two experiments were performed: in each experiment 2 groups of 70 mice were infected
with the 2 different clinical M.t uber cul osi s strains, while an additional group served as a
control.  Twenty mice from each group were left undisturbed to record survival up to day 120
after infection. Six animals from each group were sacrificed by exsanguination at 1, 3, 7, 14,
21, 28, 60 and 120 days after infection.  One lung lobe, right or left, was perfused with 10%
formaldehyde dissolved in PBS and prepared for histopathology, determining by automated
morphometry the percentage of lung surface area affected by pneumonia.  The other lobe was
snap-frozen in liquid nitrogen and used for the determination of bacilli loads by counting the
number of colony forming units (CFU) following the method previously described
(Hernández-Pando et  al ., 1996; Hernandez-Pando et  al ., 1997). All procedures were
performed in a class III cabinet in a bio-safety level III facility. Infected mice were kept in
cages fitted with micro-isolators connected to negative pressure.  Animal work was
performed in accordance with the national regulations on Animal Care and Experimentation
in Mexico.
Figure 3.2: A) Twelve year monitoring of epidemiological field site of various M. tuberculosis genotypes.
B) Two M. tuberculosis strains demonstrating different transmission chains (Van der Spuy e t a l ., 2009)
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3.1.2. Clinical hetero-resistant M. t ubercul osi s isolate
Phenotypically diagnosed drug resistant M. t uber cul osi s isolates were cultured from sputum
strains and genotypically characterised by IS 6110 DNA fingerprinting (Van Embden et  al .,
1993) and spoligotyping (Kamerbeek et  al ., 1997) using internationally standardised
methods. The DNA sequence chromatogram of the rpoB gene suggested heteroresistence by
the presence of both the wild-type and mutant sequences at codon 531.  The isolate were
plated on selective media, 7H9 supplemented with OADC, with and without 2 µg/lm RIF.
Single colonies were selected from the selective media with RIF-mono-resistant M.
t ubercul osi s was characterised by the rpoB gene 531 TTG mutation) and without the
mutation (susceptible M. t ubercul osi s ) for further analysis.  The rpoB gene in the susceptible
and RIF-mono-resistant colonies was sequenced to confirm the presence and absence of the
mutation, respectively.
3.1.3. Clinical MDR M. t ubercul osi s Beijing strain
Drug resistant M.  t uberc ul osi s bacilli were cultured from sputum samples and genotypically
characterised by IS 611 0 DNA fingerprinting and spoligotyping using internationally
standardised methods (van Embden et  al ., 1993; Kamerbeek et  al ., 1997).  The nsSNPs
conferring resistance to isoniazid, RIF, ethambutol and pyrazinamide and were determined by
DNA sequencing of the kat G , i ni A promotor, r poB , embB and pnc A genes, respectively
(Louw et  al ., 2011).  The Minimum inhibitory concentration (MIC) of RIF for the MDR
isolate was determined by inoculating a 100 µl aliquot of a mid-log phase culture into
enriched BACTEC 12B medium (Becton Dickinson, USA) containing between 2 and 200
µg/ml RIF for the analysis of RIF resistant isolates H37Rv (ATCC 35828) was included as a
RIF susceptible control (Louw et  al ., 2011).  The culture were incubated at 37oC and the
growth index (GI) for each isolate (at each RIF concentration) was measured daily for 9
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consecutive days and compared to the GI of the corresponding isolate grown (diluted 1/100)
in the absence of RIF.  The MIC for the isolate was defined as the lowest concentration of
RIF at which there was a complete absence of growth.  The experiments were done in
duplicate and were repeated on at least two separate occasions.
3.2: Freezer stock preparations of M. tuberculosis clinical strains
3.2.1. Hypo and hyper virulent M. t ubercul osi s clinical strains
Stock cultures of two genetically closely related M. t ubercul osi s Beijing genotype strains
which demonstrated vastly different pathogenic characteristics in terms of their ability to
transmit and cause disease in humans and to kill mice were inoculated into Mycobacterial
Growth Indicator Tubes (MGIT) and incubated at 37oC until positive growth was detected
using the BACTEC 960 TB system (Becton Dickson, USA).  Approximately 0.2 ml was then
inoculated onto Løwenstein-Jensen (LJ) media and incubated at 37o C for 6 weeks with
weekly aeration to provide dissolved oxygen to the media until single colony formation was
observed.  A single colony was transferred from each culture and inoculated into 20 ml 7H9
Middelbrook liquid medium (Becton, Dickinson and Company, Sparks, USA) containing
0.2% (v/v) glycerol (Merck Laboratories, Saarchem, Gauteng, SA) and 0.1% Tween80
(Merck Laboratories, Saarchem, Gauteng, SA) in 250 ml screw cap tissue culture flasks
(Greiner Bio-one, Germany) and supplemented with 10% -dextrose-catalase (DC) and
cultured at 37oC.  Primary cultures were inspected for contamination by ZN staining and
culture on blood agar plates.  Each primary sub-culture was then sub-cultured in 20 ml
Middlebrook 7H9 liquid medium supplemented with DC only and incubated at 37oC in a 250
ml tissue screw cap culture flask (Greiner Bio-one, Germany).  Growth of the secondary sub-
cultures was monitored and re-inspected for contamination.  Thereafter, 50% glycerol stocks
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were prepared and stored at -80oC. Briefly, 500µl of 50% v/v glycerol solution with H2O and
500 µl of the secondary culture with OD600=1 were mixed together in a sterile 2 ml cryogenic
tubes with O-rings and stored at -80oC.
3.2.2. Hetero-resistant M. t uber cul osi s clinical isolate
A single colony without the mutation (susceptible M. t ubercul osi s strain) and a single colony
containing the rpoB mutation (mono-rifampicin resistant M. t ubercul osi s strain), with a
Minimum Inhibitory Cconcentration (MIC) of between 100 and 200 µg/ml, were transferred
to 10 ml 7H9 Middelbrook medium (Becton, Dickinson and Company, Sparks, USA)
containing 0.2% (v/v) glycerol (Merck Laboratories, Saarchem, Gauteng, SA) and 0.1%
Tween80 (Merck Laboratories, Saarchem, Gauteng, SA) and supplemented with 10%
albumin-dextrose-catalase (ADC) in a 50 ml filter screw cap tissue culture flasks (Griener
Bio-one, , Germany) and incubated at 37oC.  The primary cultures were sub-cultured in 10 ml
Middlebrook 7H9 liquid medium supplemented with DC in a 50 ml filter screw cap tissue
culture flasks (Griener Bio-one, Germany) and incubated at 37oC until it reached an OD600 =
1.0.  Secondary sub-cultures were re-inspected for contamination and 50% glycerol stocks
were prepared and stored at -80oC as described above.
3.2.3. MDR resistant M. t uberc ul osi s Beijing isolate with high RIF MIC
One clinical isolate from the Beijing lineage cluster 220, with a S531L mutation in the rpoB
gene, and an MIC of 140 µg/ml was inoculated onto LJ solid medium and incubated at 37 oC
for 3-4 weeks with continuous aeration.  Colonies were scraped from LJ slants and incubated
in 5 ml Middlebrook 7H9 medium (Becton Dickinson, Sparks, MD 21152, USA)
supplemented with 0.2% (v/v) glycerol, 0.1% Tween 80 and 10% ADC in a 50 ml filter
screw cap tissue culture flasks (Greiner Bio-one, Germany).  After incubation for 7-10 days
at 37oC these primary sub-cultures were inspected for contamination by ZN gram staining
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and culture on blood agar plates.  The primary sub-cultures were then sub-cultured in 10 ml
Middlebrook 7H9 liquid medium supplemented with ADC and incubated at 37oC.  After 10-
14 days of growth (OD600 =0.7-0.8), the secondary sub-culture were re-inspected for
contamination and a 50% glycerol stock was prepared as described above and stored at -
80oC.
3.3: Culturing of M. tuberculosis clinical strains to mid-log growth phase
3.3.1. Culturing of M. t ubercul osi s
M. t ubercul osi s cultures for protein extraction was set up by inoculating 500 µl 50% glycerol
stock into 20 ml 7H9 Middlebrook medium supplemented with DC in a 50 ml screw cap
tissue culture flask (Greiner Bio-one, Germany) and incubated until it reached an OD600 of
0.9.  One millilitre of the culture was then used to inoculate 2 times 50 ml 7H9 Middelbrook
media supplemented with DC in a 250 ml filter screw cap tissue culture flasks (Greiner Bio-
one, Germany).  Both cultures were incubated at 37oC and the growth was monitored by
OD600.  Protein extractions were done as described below when cultures reached mid-log
growth phase (OD600 between 0.6 and 0.7).
3.3.2. RIF treated M. t ubercul o si s cultures
When each 50 ml culture in 7H9 Middelbrook medium reached an OD600 = 0.7 it was divided
into two equal portions: one half served as control (without exposure) while the remaining
half was exposed to the critical concentration (2 µg/ml) of RIF and incubated at 37oC for a
further 24 hours.  The critical concentration is defined as the drug concentration used to
differentiate between drug susceptible and drug resistant isolates. A isolate is determined as
resistant when 1% or more of the test population grows in the presence of the critical
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concentration.  This concentration was used as it would not result in a killing effect of high
and intermediate level RIF resistant isolates.  Thereafter whole cell lysate proteins were
extracted as described below.
3.4: Mycobacterial whole cell lysate protein extraction
Mycobacterial cells were collected by centrifugation (10 min at 2 500 x g ) at 4ºC and
resuspended in 1 ml cold lysis buffer containing 10 mM Tris-HCl pH 7.4 (Merck
Laboratories), 0.1% Tween-80 (Sigma Aldrich, St. Louis, MO), Complete Protease inhibitor
cocktail (1 tablet per 25 ml) (Roche, Mannheim Germany) and Phosphatase inhibitor cocktail
(1 tablet per 10 ml) (Roche, Mannheim Germany).  Resuspended cells were transferred into 2
ml cryogenic tubes with O-rings and the pellet was collected after centrifugation (2 min at 14
000 x g ; 1 min on ice; 2 min at 14 000 x g ; 1 min ice in order to prevent the protein
denaturation due to the high temperature).  An equal volume of 0.1 mm glass beads (Biospec
Products Inc., Bartlesville, OK) was added to the pelleted cells.  In addition, 300 μl cold lysis
buffer together with 10 μl RNase free DNaseI (2 U/ml) (NEB, New England Laboratories)
was added and the cell walls were lysed mechanically by bead-beating for 20 seconds in a
Ribolyser (Bio101 SAVANT, Vista, CA) at a speed of 4.0 followed by a 1 min cooling on
ice.  The lysis procedure was repeated 6 times.  The lysate was clarified by centrifugation (10
000 x g for 5 min) at 21oC and the supernatant containing the whole cell lysate proteins was
retained.  Thereafter the lysate was filter sterilised through a 0.22 μm pore acrodisc 25 mm
PF syringe sterile filters, (Pall Life Sciences, Pall Corporation, Ann Arbour, MI) and stored at
-80oC until further analysis.
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3.5: Determination of protein concentration
Protein concentrations were determined with the RCDC Protein assay (Bio-Rad Laboratories,
Hercules, CA 94547) according to the manufacturer’s instructions.
3.6: Total proteome
3.6.1. Gel electrophoresis
Fifty micrograms of whole cell lysate protein was diluted in an application buffer mixture
containing 15µl HPLC grade water, 5µl NuPAGE® LDS sample buffer (Invitrogen,
Carlsbad, CA) and 1ul 10 mM dithiothreitol (DTT) and heated for 5 min at 95oC.  Thereafter
proteins were fractionated in by SDS-PAGE using a 1.0 mm 4 - 12% Nu-PAGE gradient gel,
(Invitrogen, Carlsbad, CA) under reducing conditions for 40 min at 200V. SDS-PAGE gels
were Coomassie stained using a Colloidal Blue staining Kit (Invitrogen, Carlsbad, CA).
3.6.2. In-gel trypsin digestion
After staining, each gel lane was divided into 12 fractions for Linear Trap Quadropole
(LTQ)-Orbitrap analysis, or 10 fractions for Q Exactive analysis. Each fraction was subjected
to i n gel reduction, alkylation and tryptic digestion. Proteins were reduced in 10 mM DTT
for 1 hour at 56oC and alkylated with 55 mM iodoacetamide for 45 min at room temperature.
The reduced and alkylated peptides were digested with sequence grade-modified trypsin 1:50
wt:wt (Promega, Madinson WI) for 16 hours at 37oC in 50 mM NH4HCO3, pH 8.0.  The
reaction was quenched through acidification with 1% trifluoroacteric acid (TFA) (Fluka,
Buchs, Switzerland).  After treatment with Trypsin, peptides were extracted from gel pieces
using 50% acetonitrile (ACN) followed by washing with 100% ACN and all the washes from
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a single fraction were pooled together in one 1.5 eppendorf tube (Eppendorf, Hamburg
22331, Germany).  The total peptide extract were dried to 50 µl and the resulting peptide
mixture was desalted on RP-C18 STAGE tips (Rappsilber et  al ., 2003).  Peptides were stored
on the RP-C18 STAGE tips and eluted with 70% ACN and 0.1% formic acid (FA) and dried
to 5 µl.  The peptides diluted to a volume of 16 ul FA before mass spectrometry analysis.
3.6.3. LTQ-Orbitrap (Mass spectrometry)
All experiments were performed on a Dionex Ultimate 3000 nano-LC system (Sunnyvale
CA, USA) connected to a linear quadrupole ion trap – Orbitrap (LTQ-Orbitrap) mass
spectrometer (ThermoElectron, Bremen, Germany) equipped with a nanoelectrospray ion
source.  For liquid chromatography separation we used an Acclaim PepMap 100 column
(C18, 3 µm, 100 Å) (Dionex, Sunnyvale CA, USA) capillary of 12 cm bed length 100 micron
ID self packed with Reprosil_Pur C18-aq (Dr. Maisch Gmbh, Ammerbuch-Entringen,
Germany).  The flow rate used was 0.3 μl/min for the nano column, and the solvent gradient
used was 7% B to 40% B in 87 min, then 40-80% B in 8 min.  Solvent A was aqueous 2%
ACN in 0.1% formic acid, whereas solvent B was aqueous 90% ACN in 0.1 % FA.
The mass spectrometer was operated in the data-dependent mode to automatically switch
between Orbitrap-MS and LTQ-MS/MS acquisition.  Survey full scan MS spectra (from m/z
300 to 2,000) were acquired in the Orbitrap with resolution R = 60,000 at m/z 400 (after
accumulation to a target of 1,000,000 charges in the LTQ).  The method used allowed
sequential isolation of the most intense ions, up to six, depending on signal intensity, for
fragmentation on the linear ion trap using collisionally induced dissociation at a target value
of 100,000 charges.
For accurate mass measurements the lock mass option was enabled in MS mode and the
polydimethylcyclosiloxane (PCM) ions generated in the electrospray process from ambient
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air were used for internal recalibration during the analysis (Olsen et  al ., 2005).  Target ions
already selected for MS/MS were dynamically excluded for 60 seconds.  General mass
spectrometry conditions were: electrospray voltage, 1.5 kV; no sheath and auxiliary gas flow.
Ion selection threshold was 500 counts for MS/MS, and an activation Q-value of 0.25 and
activation time of 30 ms were also applied for MS/MS.
3.6.4. Q Exactive-Orbitrap (Mass spectrometry)
The proteome analysis was performed using a nanoflow Dionex Ultimate 3000 nano-LC
system (Sunnyvale CA, USA) coupled online to a Q Exactive mass spectrometer (Thermo
Fisher scientific, Bremen, Germany) via a Proxeon nanospray source, operated at 2.4kV.
Each sample were analysed in triplicate and 4 ul of peptide mixture were injected for each
replicate.  The peptides were loaded in solvent A (0.1% FA in aqueous solution) in a ViperTM
capillary column packed with C18 resin with a bed length of 15 cm (75 µm internal diameter,
3 µm beads, 75 µm internal diameter, beads, Bremen, Germany) with a flow rate of 5 µl/min.
Peptides were eluted using a linear 10-32% gradient of solvent B (90% ACN and 0.1% FA)
during 120 min, with a flow of 300 nl/min.
Mass spectra were acquired using a data dependant method with an automatic switch between
a full scan and choosing the 10 most abundant precursor ions from the survey scan MS/MS
scans.  The target value for the full scan MS spectra were 1e6 ion and resolution was 70,000
at m/z 200.  MS/MS was performed by higher-energy collisional dissociation (HCD)
fragmentation with a collision energy value of 30%, with target value of 1e6 ions or 120ms
injection time.  MS/MS spectrum was collected in the Orbitrap cell with a resolution of
35,000 at m/z 200.  Ions were dynamically excluded for 45s after ion selection for MS/MS.
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3.7: Data analysis
3.7.1. Exponentially Modified Protein Abundance Index (EmPAI)
3.7.1.1. Mascot search and peptide/protein validation
MS/MS peak lists from individual 48 RAW files (24 from the hypo-virulent and 24 from the
hyper-virulent strains) were generated using DTA SuperCharger package, version 1.29,
available at the MSQuant validation tool (see below).  Protein identification was done by
searching the data separately against the M. t ubercul osi s H37Rv protein database available at
the Tuberculist website (version R11 tuberculist.epfl.ch).  The databases were in-house
modified to also contain reversed sequences of all entries as a control of false-positive
identifications during analysis.  Common contaminants, such as keratins, BSA and trypsin,
were also added to the database.  MASCOT Daemon was used for multiple searches
submission on a local Mascot server v2.1 (Matrix Science).  The search parameters used
were: Maximum missed cleavages: 3; Carbamidomethyl (C) as fixed modification; N-acetyl
(Protein), Oxidation (M), pyro-glu (Q) and pyro-glu (E) as variable modifications; Peptide
mass tolerance of ± 15 parts per million; MS/MS mass tolerance of 0.5 Da.  Under these
criteria, Mascot indicated a minimal score of 22 for p ≤ 0.01 and 15 for p ≤ 0.05.  All data
had a mass accuracy average of 4.1 parts per million.  Spectra and protein validation were
performed using an open source software called MSQuant (version 1.5a61), largely used for
LC-MS/MS data analysis.  Proteins were validated statistically, based on the score of their
individual peptides.  Proteins with at least two tryptic peptides with a minimal score of 22 for
each (protein false-positive probability of 0.01%), or those with only 1 peptide but a MS/MS
score higher than 38 were accepted (protein false-positive probability lower than 0.25%).
Using these criteria, all MS/MS identifications of peptides present in entries with reversed
sequences (i.e. false-positive identifications) were not validated, since none of the reversed
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proteins were identified with 2 peptides with a score higher than 21 each or 1 peptide with a
score higher than 38 (the highest Mascot score for a peptide from the reversed database was
32 – data not shown).  Identifications with only one unique peptide were accepted only after
manual validation.  Quality criteria for manual validation were the assignment of major
peaks, the occurrence of uninterrupted y- or b-ion series of at least 3 consecutive amino acids,
the preferred cleavages N-terminal to proline bonds and C-terminal to Asp or Glu bonds, and
the possible presence of a2/b2 ion pairs.
3.7.1.2. Protein abundance estimation
The peptide list was submitted to the emPAI calculation tool, and emPAI values for
individual proteins identified in each sample were obtained (Ishihama et  al ., 2005).  Before
the submission of the data, genes Rv1198 , Rv179 3 and Rv2346c were manually merged, and
renamed the complex to ESATx-like.  This was done because it is impossible to determine
which of those proteins are contributing the tryptic peptides that are shared between them
(these 94 amino acids long proteins share 86 identical amino acid residues).  Protein
abundance expressed as emPAI values was calculated using the number of observable
peptides and the number of observed parent ions per identified peptide.  The number of
observable (or expected) peptides for a protein was calculated through i n si l i co trypsin
digestion of the M. t uberc ul osi s H37Rv database, and the resulting peptide fragments were
compared with the scan range of the mass spectrometry.  The emPAI values were calculated
using a script developed at the Keio University (Japan) (available at
http://empai.iab.keio.ac.jp/), using the following parameters: trypsin enzyme,
Carbamidomethyl (C) fixed modification, mass range from 300 to 8,000 Da, no retention
time filtering, Bold red peptides only (i.e., unique peptides in the Mascot result), peptides
filtered by peptide Mascot score higher than 21.  The Protein Abundance Index (PAI) was
obtained by division of the observed parent ions with the number of theoretical observable
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peptides; emPAI is obtained using the formula emPAI = 10PAI – 1.  The protein concentration
in the sample was calculated as mol% by dividing individual emPAI values by the sum of all
values within a sample, and multiplied by 100.  This step is not only important for measuring
the mol% of a protein, but also to normalize any difference in emPAI values observed
between samples due to differences in instrument efficiency during different.  To determine
differentially represented proteins between the hypo- and the hyper-virulent M. t ubercul osi s
strains, we merged the peptide list identifications of two independent replicates per strain.
Individual mol% values were compared, and proteins were divided in two categories as
follows: i) for proteins identified in both samples, the difference in relative concentration
between the strains had to be higher than 4 fold; b) for a protein identified in only one of the
strains, we required that it had to be identified with a minimal of three parent ions, and we
selected a mol% of 0.02 as a threshold.  Such stringent criteria are required to guarantee that
a protein identified in only one sample is most probably due to differences in abundance
between the samples, and not because parent ions were not identified (but still present) in the
MS analysis due to random fluctuation of the MS/MS data-dependant acquisition procedure.
3.7.2. MaxQuant
The acquired raw files (total proteome MS/MS files of susceptible, rifampicin (RIF)-mono-
resistant, and MDR) were analysed by MaxQuant (version 1.2.2.5) (Cox and Mann, 2008).
Andromeda, a probabilistic search engine incorporated into the MaxQuant framework was
used to search the peak lists against the Tuberculist R21 database.  Common contaminants
like keratins, BSA and trypsin were automatically added to this database by the software.
The search included enzyme specificity: Trypsin/P; maximum missed cleavages: 2;
carbamidomethyl (Cys) as fixed modification; and N-acetyl (protein), oxidation (Met), pyro-
glu (Gln) and pyro-glu (Glu) as variable modifications.  For statistical evaluation of the data
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obtained, the posterior error probability and false discovery rate were used.  The false
discovery rate of 0.01 for proteins and peptides were required.  The peptide identification was
based on a search with an initial mass deviation of precursor ion of up to 20 ppm, with further
data recalibrations and new search with a 6 ppm deviation.  MS/MS mass deviation was set to
20 ppm for Q Exactive data, and 0.5 Da for any LTQ-Orbitrap data.  To match identifications
across different replicated and adjacent fractions the “match between runs” options in
MaxQuant was enabled within a time window of 2 min.
3.7.3. Perseus statistical analysis tool
The bioinformatics analysis was done with Perseus tools available in MaxQuant environment
(http://Perseusframeowrk.org).  For the analysis the missing values were replaced using data
imputation.  The aim to perform imputation of missing values is that they should simulate
signals of low abundant proteins instead of presenting absent proteins (not published).
For the comparative label-free analysis of the proteome of the hypo and hyper-virulent M.
t ubercul osi s significant proteins in each strain was determined using a t-test with Permutation
– based FDR correction to calculate the p-value with a threshold < 0.01 using the Perseus
tool.  The differentially abundant proteins in each strain were determined by the odds ratio.
To determine the differentially abundant proteins in each strain relative to the other strain we
used the significant p-value combined with the average iBAQ ratio [hyper-virulent
strainaverage iBAQ intensities/hypo-virulent strainaverage iBAQ intensities].
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3.8: Phosphoproteome
3.8.1. Filter Aided Sample Preparation (FASP)
Four milligrams of concentrated whole cell lysate protein was heated in 4% SDS buffer to
ensure complete homogenisation and denaturation.  The protein concentration was measured
by using the RCDC assay (as described in above) and 250 µl of the lysate proteins was
loaded onto a 15 ml Amicon filtration device (10kDAa MWCO) (Millipore) and centrifuged
at 2000 x g for 40 min at 25oC.  The flow through was collected in a clean falcon tube.
Subsequently, the rest of the lysate proteins were diluted in the filtration device and
centrifuged twice more for 15 min and the elute was collected in a separate falcon tube.  The
flow through of the second and third centrifugation was collected in separate falcon tubes.
The concentrated proteins were washed with 20 ml Tris buffer (UA buffer) containing 8M
Urea in 0.1M Tris/HCl pH 8.5 to remove SDS.  The concentrated proteins (final volume of
250 µl), were alkylated by mixing proteins with 1.5 ml 50 mM iodacetamide (IAA) and
incubated in the dark for 20 min. The alkylated proteins were concentrated by centrifugation
for 17 min at 20 000 x g at 25oC to obtain a volume of 250 µl.  The excess IAA was removed
by multiple washes with 2 ml UA buffer and centrifuged at 20000g for 15 min.  Thereafter
the proteins were washed with 4 ml 50 mM ammonium bicarbonate (ABC) and concentrate
by centrifugation at 20000 x g for 17 min until 250 µl.  The proteins were equilibrated by
washing twice with 4 ml 20 mM ABC until final volume of 250 µl with trypsin (Promega) in
a protein to enzyme ratio of 100:1 at 37oC for 16 hrs.  After digestion the peptides were
eluted with 50 µl of water to avoid desalting for further processing of the peptides.
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3.8.2. Phosphopeptide enrichment
3.8.2.1. Strong Cation Exchange Chromatography (SCX)
Strong cation exchange chromatography is frequently used as a separation method for
complexity reduction in proteomic studies.  Trypsin digested peptides were diluted in SCX
solvent A (5 mM KH2PO4/30% ACN, pH 2.7) to 7 ml, the pH were adjusted to 2.7 and then
adjusted to 10 ml with 100% ACN (Beausoleil et  al ., 2004).  The peptides were then
separated by strong cationic exchange chromatography (SCX) as described below.  Briefly,
the peptide mixture was loaded onto cationic exchanger column equilibrated (washed) with 2
ml 30% ACN containing 5 mM KH2PO4 (pH 2.7).  The flow through which predominantly
contains multiply phosphorylated peptides was collected.  The peptides bound to the column
were eluted in an increasing salt gradient with buffer containing 5 mM KH2PO4 (pH2.7) and
150 mM KCl.  The flow-through from the SCX column was also used as one fraction
(salvage fraction).
3.8.2.2. Enrichment of phosphopeptides with Titanium dioxide (TiO2)
The flow-through and seven SCX fractions were subjected to TiO2 enrichment with 4
consecutive incubations for the flow through and1 incubation each for the remaining 7
fractions as described.  The UV absorbance of the fractions was measured using the nano
drop and they were incubated with TiO2 (MS-Analysentechnik, Germany) with a peptide to
bead ratio of 1:2 (Qing-Run Li, 2009).  Before mixing the fractions 5 mg TiO2 beads re-
suspended in 10 ul 30 mg/ml dihydrobenzoic acid (DHB) solution to prevent non-specific
binding of non-phosphorylated peptides.  DHB solution is prepared by dissolving 30 mg of
DHB powder in 75% acetonitrile containing 0.1% (Trifluoracetic acid) TFA.  The fractions
were rotated for 30 min and after incubation and briefly centrifuged.  The supernatant was
transferred to a newly labelled tube.  The phosphopeptides bound beads were washed twice
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with 200 µl 30% ACN and 3% TFA followed by two washes with 200 ul 75% ACN and
0.3% TFA.  The enriched phosphorylated peptides were then eluted with 40 µl elution buffer
(25% DHB and ACN with pH 10) under basic conditions.  The eluted phospho-peptides were
desalted using C18 Stage tips (as described above) (Rappsilber et  al ., 2003) .
3.8.3. LTQ-Orbitrap-Velos (Mass spectrometry)
The peptides were separated in a column packed in-house with C18 beads on a Proxeon
Easy-nLC system using a binary gradient provided by buffer A (0.5% acetic acid and buffer
B (0.5% acetic acid and 80% ACN).  The peptides (4 µl) were eluted directly without any
trapping column with buffer A at a flow rate if 500 nl/min.  Elution was carried out at a flow
rate of 250 nl/min, with a linear gradient from 10% to 35% buffer B in 95 min followed by
50% B for 15 min.  At the end of the gradient the column was washed with 90% B and
equilibrated with 5% B for 10 min.  The LC system was directly coupled in-line with the
LTQ-Orbitrap Velos instrument (Thermo Fischer Scientific, Bremen, Germany) via the
Proxeon Biosystems nanoelectrospray source ( Pr oxeon Bi osyst ems , Denmark).  The source
was operated at 2.1-2.25 kV, with no sheath gas flow, with the ion transfer tube at 200oC.
The mass spectrometer was programmed to acquire in a data dependant mode.  For the high-
high strategy, survey scans were acquired in the Orbitrap mass analyser with resolution
30,000 at m/z 400 with lock mass option enabled for the 445.120025 ion.  However the target
lock mass abundance was set to 0% instead of 5-10% in order to save the injection time for
the lock mass.  For the full scans 1E6 ions were accumulated within a maximum injection
time of 250 ms in the C trap and detected in the Orbitrap analyser.  The ten most intense ions
with charge states ≥ 2 were sequentially isolated (signal threshold of 10,000) to a target value
of 3E4 with a maximum injection time of 150 ms and fragmented by HCD in the collision
cell (normalised collision energy of 40% ) and detected in the Orbitrap analyser at 7,500
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resolution.  For the high-low strategy using CID, full scans were acquired in the Orbitrap
analyser at 60,000 resolution because parallel acquisition in enabled in the high-low mode.
Up to the 20 most intense peaks with charge state ≥ 2 were selected for sequencing (signal
threshold of 1000) to target value if 5, 000 with a maximum injection time if 25 ms, isolation
window of 2Th and fragmented in the top ion trap by collision induced dissociation with
normalised collision energy of 35%, activation q = 0.25, and activation time of 10ms.  For
CID wideband activation and multi-stage activation options were enabled with the
appropriate neutral loss mass list for singly, doubly and triply phosphorylated peptides.  The
fragmentation spectra were acquired in the ion trap at normal scan rate by lateral ejection and
recorded by the dynode-multiplier system. For all sequencing events dynamic exclusion was
enabled to minimize repeated sequencing.  Peaks selected for fragmentation more than once
within 30 s were excluded from selection (10 ppm window) for 60 s.
3.8.4. Data analysis –MaxQuant
The raw data acquired were processed using MaxQuant software version (1.2.2.5) and
processed as per standard flow.  Since the HCD spectra were acquired in profile mode, de-
isotoping was performed similar to survey MS scans to obtain singly charged peak list.  Peak
lists generated from the ‘quant’ module were searched against the M. t u bercul osi s H37Rv
protein database (version R11 tuberculist.epfl.ch).  For the high-low strategy these values
were 7 ppm and 0.5 Th, respectively.  The search included cysteine carboaminomethylation
as a fixed modification, and N-acteylation of protein, oxidation of methionine, and
phosphorylation of Ser, Thr and Tyr were used as variable modification.  Up to two miss
cleavages were allowed for protease digestion and peptide had to be fully tryptic. The
identify module in MaxQuant was used to filter identifications at 1% false discovery rate
(FDR) at three levels namely, site, peptide and protein.  As such there is no fixed cut-off
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score threshold but instead spectra are accepted until the 1% FDR rate is reached.  Only
peptides with minimum length of 7 amino acids were considered for identification.
3.8.5. Statistical analysis
To determine the intensity of each phosphorylated protein the average of the intensities of the
phosphorylated peptides for each protein per replicate were calculated. The p - val ues for each
of the phosphorylated proteins identified were manually calculated in this study. A
significant p-value threshold <0.05 were used to determine the number of phosphorylated
proteins identified with high confidence.  To determine the relative abundance of each
phosphorylated protein in each strain relative to the other strain we used the significant p-
value combined the average iBAQ ratio [hyper-virulent strainaverage intensities/hypo-virulent
strainaverage intensities].
3.9: Transcriptomics
3.9.1. Culturing for RNA extractions
All subsequent experiments were set up as 2 biological (to assess biological measurements
for two independent experiments done on different days) and 2 technical replicates (repeated
measures of one biological sample on the same day) for each isolate.  Each experimental
culture was set up by aliquoting 800 μl of the secondary sub-culture in 40 ml supplemented
7H9 medium (1:100 dilution) and incubated at 37°C until mid-log phase (OD600= 0.7-0.8).
Once the cultures reached mid-log phase, 200 ml of Guanidine-thiocyanate (GITC) (Sigma-
Aldrich, St.Louis, USA) solution (5M GTC, 0.5% sodium N- lauroyl sarcosine, 0.1M H-
mercaptoethanol, 12.5 ml of 1M sodium citrate pH7.0 and 1% Tween 80 made up to 500 ml
with RNase free water) was added to each 40 ml culture.  Cells were harvested by
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centrifugation (3000 x g , 15 min, 20oC) and the supernatant was discarded.  The pelleted cells
were then resuspended in 1 ml of TRIzol (Life Technologies, Gaithersburg, MD).  The
suspension was transferred to a 2 ml screw capped tube containing silica beads (IEPSA
Medical diagnostics, South Africa) and ribolyzed (reciprocal shaker, Hybaid) at 6 W for 20
seconds.  Thereafter tubes were cooled on ice for 1 min between pulses.  The ribolysis was
repeated 3 times. Samples were centrifuged at 13000 rpm for 1 min and the TRIZOL
solution above the beads was transferred to a 2 ml phase lock gel tube (Eppendorf, Hamburg
22331, Germany) containing 300 µl chloroform/isoamyl alcohol (24:1) (Sigma-Aldrich, St.
Louis, Germany). Tube were inverted several times and then centrifuged at 13000rpm for 10
min.  The top aqueous layer was transferred to a new 1.5 ml tube and the crude RNA was
precipitated with the addition of an equal volume of isopropanol (Merck, Darmstadt,
Germany). Samples were incubated at -20oC overnight.  The crude RNA were collected by
centrifugation at 12000 x g, 30 min at 4oC and the pellet was washed with 70% ethanol
(Merck, Darmstadt, Germany). RNA pellets was air-dried and dissolved in 70 µl RNase-free
water.  Contaminating chromosomal DNA was digested by typically adding 4 µl DNase and
4 µl DNase buffer (Whitehead Scientific) to 15 µl extracted RNA, followed by incubation at
37oC for 30 min.  The DNase treated RNA was made up to a final volume of 200 µl with
RNase-free water.  An equal volume of Phenol:Chloroform (4:1) (Sigma-Aldrich, St. Louis,
Germany) was added to the diluted RNA, gently mixed and left on ice for 10 min. Tubes
were centrifuged at top speed for 10 min at room temperature.  The top aqueous layer was
transferred to a new tube, 0.1 volumes of RNase-free sodium acetate pH 5.2 and 2.5 volumes
of 100% RNase-free Ethanol (Merck, Darmstadt, Germany) were added and incubated at -
20oC overnight.  The RNA was collected by centrifugation at 12000 x g , 30 min at 4oC ,
washed with RNase-free 70% ethanol (Merck, Darmstadt, Germany), recollected by
centrifugation at 12000 x g , for 10 min at 4oC and the ethanol was aspirated off. Purified
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RNA was air-dried and re-dissolved in 70 µl RNase-free water.  The quantity and quality of
the RNA extracted from each culture was determined by measuring the A260/A280 ratio
spectrometrically and electronically observed on a virtual gel electrophoresis on the Experion
Software version 2.01 (Bio-rad).  The RNA preparations were only considered acceptable for
subsequent analysis if the presence of the dominant 16S and 23S rRNA species appeared as
fairly sharp bands, the A260/A280 ratio was between 1.8 and 2.1 and no high molecular
weight DNA was detected.
3.9.2. cDNA synthesis
cDNA was synthesized from 0.5 µg highly purified RNA using a Reverse transcriptase kit
according to the manufacturer’s instructions (Southern Cross Biotechnologies).  In short, 0.5
ug RNA was mixed with 2 µl genomic DNA Whipeout buffer and RNase-free water (total
volume of 14 µl) and incubated for 2 min at 42oC.  After the incubation 14 µl Quantscript
Reverse Transcriptase, 4 µl Quantscript RT buffer and 1 µl RT Primer mix was added to the
RNA mix and incubated for 20 min at 42oC. Therafter the mix was incubated for 3 min at
95oC to inactivate the Quantscript Reverse Transcriptase.
3.9.3. Primer design for Quantitative Real time PCR of candidate genes
Oligo nucleotides (primers) for quantitative reverse transcriptase analysis of the candidate
genes were designed against the whole genome sequence of the M. t ubercul osi s H37Rv
reference strain (http://genolist.pasteur.fr/TubercuList) using the internet based Primer
software 3 version 0.4.0 (Whitehead Scientific, South Africa).
The primers were designed to be 18 and 20 bp and a G+C content between 50-60% and to
anneal to unique sequences within the target genome.  For any primer pair, a maximum
melting temperature (Tm) difference of 2oC was allowed.
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Table 3.1: Quantitative real time PCR of candidate genes
Rv number Gene name Primer sequence Tm Reference
Rv0015c P k n A Forward: 5’gcaggtgaagatcaccgact 3’
Reverse: 5’tacccgaaaccgcttcatac3’
60oC Current
Rv0014c P k n B Forward: 5’ggacatgaacccggatattg3’
Reverse: 5’tcgtttgactaccagcaacg3’
60oC Current
Rv0931c P k n D Forward: 5’gtttatgaggccgaggacac3’
Reverse: 5’ggtcagcggaccatactgtt3’
60oC Current
Rv1743 P k n E Forward: 5’gacgtcaaaccggagaacat3’
Reverse: 5’gagctggtctccctgatacg3’
60oC Current
Rv1746 P k n F Forward: 5’atcccttctcagggatcgtt3’
Reverse: 5’catgattcgacgatcaggtg3’
60oC Current
Rv0410c P k n G Forward: 5’tcaactttgtcgagcacacc3’
Reverse: 5’atgatgttttccggcttcag3’
60oC Current
Rv2176 P k n L Forward: 5’atgtcaagcccgagaacatc3’
Reverse: 5’ccgttagcagctcgtagacc3’
60oC Current
Rv1747 - Forward: 5’cagacgacgtcgatacgc3’
Reverse: 5’catcgatggtccaggtcac3’
60oC PhD thesis (Louw GE, 2009)
3.9.4. Quantitative real-time PCR (qRT-PCR)
The standard curve method was used for relative quantification and the mycobacterial 16S
ribosomal RNA for reference constitutive gene expression.  The standard curve method for
relative quantification is based on the construction of standard curve of cycle number at a
threshold (CT) against initial input amount of total RNA or copy number. This method
assumes an approximately equal amplification efficiency of the PCR among the diluted
samples of the same gene, thus producing a linear relationship of CT against initial input
amount of total RNA or copy number.  In this study the standard curve method was used for
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relative quantification of the reference gene and the candidate genes on both biological and
technical duplicate samples.
A standard 20 µl PCR reaction was setup by adding 2 µl of light Cycler Fast start DNA
Master plus SYBR Green I reaction mix (Roche Applied Science, Germany), 1 µl forward
and reverse primer (10 µM of each candidate gene, 14 µl of RNase-free water and 2 µl of
diluted cDNA (dilution series of hypo- and hyper-virulent samples).  A negative control was
included which contained the same mix without the sample.  The PCR mix was transfered to
the capillary tubes (Roche Applied Science) in a pre-cooled adapter block after which it was
removed and centrifuged and centrifuged at 15 rpm for 3 seconds.  The capillaries were
placed in a the light cycler 2.0 instrument (Roche Applied Science) and cycled through a four
step PCR parameter protocol: (i) Activation program (95oC for 15 min); (ii) RT- PCR
programme repeated for 45 cycles (95oC for 15s, 60oC for 30s, 72oC for 30s); (iii) Melting
curve programme (95oC for 0s, 60oC for 15s, 95oC for 0s with a heating rate of 0.1oC/s); (iv)
Cooling down programme for 10 sec.  The primer optimisation and the PCR efficiency of
each gene were optimised using H37Rv.
3.9.5. Data analysis
16S rRNA was included as reference genes and used for normalisation of RNA levels,
because in the experiments 16S rRNA expression levels are the most stable.  The level of
gene transcription of each individual gene was quantified using the delta-delta CT calculation
in which the relative abundance of the target gene was normalised relative to the levels of the
reference RNA transcripts (16S rRNA).  Significant fold changes were identified based in
The Relative Expression Software Tool (REST-384) that assigns significance with a
significance level of 5%.  The data analysis were done according to the delta-delta CT
equation R= PCR efficiency of the target gene –(ΔCT hyper-virulent M . tb strain – ΔCT hypo-virulent M .t b strain).
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3.10: Bioinformatics analysis tools
Table 3.2 summarises a list of free online available bioinformatics tools used in this thesis.
The search engine MASCOT uses mass spectrometry peptide data to identify proteins from
primary sequence databases (Perkins et  al ., 1999).  The Tuberculist database and website
intergrates genome-, proteome-, transciptome- and drug data, literature, structural views,
mutatnt and operon annotation in a structured manner inorder to broaden the view of M.
t ubercul osi s (Lew et  al ., 2011).  The Pathosystems Resource Intergration Centre (PATRIC) is
a freely available bacterial bioinformatics resource centre providing vital information on
infectious diseases and pathogen information with data and analysis tools (Gillespie et  al .,
2011; Snyder et  al ., 2007). The Tuberculosis database (TBDB) is an open access source
where published data on tuberculosis are freely available (Reddy et  al ., 2009). The TMHMM
server v. 2.0 is a prediction server which can determine the number of transmembrane helices
based on a hidden Markov model (Sonnhammer et  al ., 1998).
Tabel 3.2: List of online databases used for bioinformatic analysis of the proteins identified in this study:
Database Online reference Reference
MASCOT http://www.matrixscience.com/ (Perkins e t a l ., 1999)
Tuberculist http://tuberculist.epfl.ch/ (Lew e t a l ., 2011)
PATRIC http://www.patricbrc.org/ (Snyder e t a l ., 2007;
Gillespie e t a l ., 2011;)
TBDB http://www.tbdb.org/ (Reddy e t a l ., 2009)
TMHMM Server v. 2.0 http://www.cbs.dtu.dk/services/TMHMM/ (Sonnhammer e t a l ., 1998)
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3.11. List of buffers and solutions
3.11.1. Culturing:
Middlebrook 7H9 liquid medium 7H9 Middlebrook medium 4.7 g
dH2O 900 ml
Glycerol 2 ml
Polysorbate (Tween80) 1 ml
ADC supplement BSA 25 g
Glucose 10 g
Catalase 0.75 ml
dH2O make up to 500 ml
DC supplement Glucose 10 g
Catalase 0.75 ml
dH2O make up to 500 ml
3.11.2. Protein extraction:
Extraction buffer 10 mM Tris-HCL pH 7.4 500 µl
Tween-80 3 µl
1 Protease inhibitor tablet per 25 ml
1 Phosphatase inhibitor
cocktail tablet per 10 ml
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dH2O make up to 25 ml
3.11.3. RNA extraction:
5M GITC Guanidine thiocyanate 295.4 g
Sodium N-Lauroyl Sarcosine 25 g
ß-mercaptoethanol 3.5 ml
1 M Sodium citrate pH 7.0 12.5 ml
Tween80 5 ml
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CHAPTER 4
Label-free quantification of closely related hypo-and hyper-virulent M.
tuberculosis strains using Estimated Protein Abundance Index (emPAI)
This chapter is structured for publication (Published format see appendix)
My contribution to this chapter: Culturing of M. tuberculosis strains
Protein extractions
Sample preparation for Mass Spectrometry analysis
Writing of Manuscript
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4.1: Aim:
In this study, we used high throught-put mass spectrometry in combination with Estimated
Protein Abundance Index (emPAI) calculations to describe proteomic differences between
two closely related M. t ubercul osi s Beijing genotype strains.  These strains have vastly
different pathogenic characteristics in terms of their ability to transmit and cause disease in
humans and to cause pulmonary damage in mice.
4.2: Results:
4.2.1. Experimental model of pulmonary tuberculosis in BALB/c mice infected
with hypo- and hyper-virulent M. tuberculosis Beijing strains
Mice infected with the actively transmitting strain started to die three weeks after infection
and by 5 weeks all the mice had died (figure. 4.1A).  Culture of lung homogenates showed
very high lung bacillary loads (figure. 4.1B), while histopathology showed extensive tissue
damage (pneumonia) which started at day 14 post infection (figure. 4.1C).
Figure 4.1: Virulence of M.tuberculosis clinical isolates in a murine infection model. BALB/c mice were
infected by intratracheal injection (2.5x105 bacilli) with selected Beijing strains.  The virulence of the strain
representative of the largest cluster (white symbols) was compared to the virulence of the non-transmitting strain
(black symbols). A) Kaplan–Meier survival curves. B) Bacillary loads. C) Morphometry (% of lung surface
area affected by pneumonia).  Asterisks represent statistical significance (p<0.005).
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Based on these results we assigned a virulence status of hyper-virulent to this Beijing strain.
Animals infected with the unique Beijing strain (non-transmitting) showed 80 to 90%
survival after 4 months of infection (figure. 4.1A) and a tenfold lower number of colony
forming units (CFU) in the lungs (figure. 4.1B).  Histopathology showed extensive tissue
damage (pneumonia) which started at day 14 post infection (figure. 4.1C).  Based on these
results we assigned a virulence status of hypo-virulent to this Beijing strain.
4.2.2. Proteome of the hypo-and hyper-virulent M. tuberculosis Beijing strains
To identify differences in abundance of proteins in the two Beijing genotype strains, whole
cell lysate proteins were subjected to Gel-LC-MS/MS approach (figure 4.1) (Aebersold and
Mann, 2003).  The electrophoretic protein profile of both strains is almost identical (data not
shown) (Lew et  al ., 2011).
Figure 4.2: Workflow of the quantitative label-free proteomics approach using EmPAI
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All mass spectrometry data obtained was identified using Mascot, and were submitted for
identification against the M. t uber cul osi s H37Rv lab strain protein database (Tuberculist)
(Cole et  al ., 1998; Lew e t  al ., 2011).  This reference database was used since previous studies
have suggested that this gene annotation is the most reliable (Lew et  al ., 2011).
Figure. 4.3: MS/MS profile of ion m/z 601.41. Tandem mass spectrum of a prevalent ion on a particular time
point in the LC gradient and ionized on the LTQ-Orbitrap.  The peptide fragments randomly on each amide
bond, resulting in carboxy-terminal y ions or amino-terminal b ions.  After the fragment masses were submitted
to Mascot, the peptide was identified as FGDQVVAVLTR (inset, with detected y and b ions represented) from
protein Rv3220c – probable two component sensor kinase.
Figure 4.3 illustrates an example of a MS/MS spectrum of a peptide of m/z 602.84. The
Mascot tool identified it as the peptide FGDQVVAVLTR, corresponding to the protein entry
Rv3220c, annotated as “Probable two component sensor kinase”.  This identification had a
mass accuracy of 4.4 ppm between observed and theoretical masses.  Figure 4.3 also
illustrates the fragmentation pattern and identification of y/b series of the sequence (sequence
input).  In this example Mascot was able to correlate the full y ion series, and 8 of 10 b ions,
which resulted in a Mascot identification score of 81 (score 22 represents a p<0.01).
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The whole proteome analysis of both replicates for each sample identified a total of 1443
proteins for the hypo-virulent strain, and 1524 proteins for the hyper-virulent M. t ubercul osi s
strain.  Merging both datasets, we identified the protein products of 1670 of the 4066 genes
predicted by Tuberculist.  From these, 145 proteins were identified only in the hypo-virulent
cells and 226 were identified only in the hyper-virulent M. t ubercul osi s strain.  The majority
of these proteins observed in only one strain represent identifications based on one or two
peptides, and in these cases those proteins were not used for quantitative comparison.
Figure 4.4: Venn diagram of proteins identified in hypo-and hyper-virulent M.  tu b e rc u lo s is strains
Appendix file 4.1 reports all peptides identified in whole lysate protein extract from the two
Beijing genotype strains, their protein mass, number of peptides per identified protein
(Pep/Prot), peptide length, observed charge, observed m/z ratio, measured peptide mass (Da),
Mascot Score, the presence of modifications (as N-terminal acetylation or Met oxidation),
and the error of the observed / theoretical mass in ppm.
4.2.3. emPAI analysis and data comparison
After normalization and mol% calculation, all mol% values from proteins present in both
samples were plotted in a logarithmic linear distribution graph (figure. 4.2).
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Figure 4.5: Protein abundance comparison of hypo- and hyper-virulent M. tuberculosis strain. Protein
abundance was derived from emPAI values.  Solid lines delimit differentially abundant proteins (external area)
from similarly abundant (internal area).
This analysis showed that most of the 1298 proteins lie within a difference range of less than
3 fold (figure 4.5).  This indicates not only that the normalization is reliable, but also that the
relative quantitation provided by emPAI is relatively accurate, since the majority of proteins
in this comparison are equally distributed between the two data sets.  Appendix file 4.2
contains all emPAI values obtained for each strain and a sheet with the merged results for
both strains.
4.2.4. Identification of differentially abundant proteins
Once mol% was calculated and samples compared, we set stringent thresholds to indicate
proteins differentially represented in each Beijing strain, as shown in the Methods section.
When these chosen criteria were applied to our dataset, only 53 entries from the hyper-
virulent strain and 48 from the hypo-virulent M. t ubercul osi s strain were selected.  Empai
values for those entries can be seen in appendix file 4.2 in green and a short description of
these entries is also reported in appendix file 4.3 (Correspond to supplementary file S3).
Figure 4.6 shows these differential proteins grouped according to the functional category as
given in Tuberculist.  Interestingly, proteins in functional categories 3 (cell wall and cell
processes) and 9 (regulatory proteins) are significantly over-represented in the hyper-virulent
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strain while proteins from the functional category 1 (lipid metabolism) are more evident in
the hypo-virulent strain.
Figure 4.6: Functional classification of differentially abundant proteins. Proteins were classified according
to Tuberculist’s functional category groups.  Grey bars represent proteins more abundant in the hypo-virulent
strain, and black bars in the hyper-virulent M.  tu b e rc u lo si s strain.  FC10 represents the group of conserved
hypothetical proteins.
4.2.5. In-vivo RT-PCR measurements
Since ESAT-6 is an exported protein, intracellular accumulation of this protein demonstrated
by proteomics could be a result of gene expression changes or changes in membrane transport
machinery.  Further validation of gene expression levels of ESAT-6 and CFP10 was
performed in-vivo, during several time points of the infection (figure 4.7). Figure 4.7A
shows the quantitative information of ESAT-6 from mice infected with one or the other strain
was normalized against the number of copies of 16S, used as a control. Figure 4.7B
demonstrates the absolute values of gene copies divided by 1 CFU.  The results showed that
ESAT-6 gene expression was reduced in the hyper-virulent strain (white bars).  CFP10
showed a similar reduction, but to a lesser extent data (data not shown).
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Figure 4.7: Validation of gene expression levels of ESAT-6 and CFP10 was performed in-vivo, during
several time points of the infection.  A) Quantitative information of ESAT-6 from mice infected with one or the
other strain was normalized against the number of copies of 16S, used as a control.  B) Absolute values of gene
copies are divided by 1 CFU. Black bars represent hypo virulent strains and white bars represent hyper-virulent
strain
4.3: Discussion
The identification of virulence factors from M.  t ube rcul osi s involved in the TB disease
process is not only a crucial step to understand the pathogen’s biology, but may also provide
insights into regional TB epidemiology which in turn may improve treatment regimens in the
long run.  The release of the M. t u bercul osi s H37Rv lab strain genome (Cole et  al ., 1998) and
further availability of other genomes of the M. t ubercul osi s complex such as M. bovi s , the
attenuated M.  bovi s BCG vaccine strain and the clinical isolate, M.  t ube rcul osi s CDC1551,
has allowed many genomic comparisons in order to discover regions in the genome with gene
mutations or gene deletions that result in a more or less virulent phenotype (Campuzano et
al ., 2007; de Souza et  al ., 2008).  However, it can be expected that many factors participating
in virulence of a strain cannot be directly identified at the genomic level, and information
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regarding gene expression and protein abundance can contribute greatly to improve our
understanding in this field.
To test this hypothesis, we employed a MS-based proteomic approach coupled with a label-
free abundance estimate to identify proteins present in two clinical M. t ubercul osi s Beijing
strains isolated from TB cases in South Africa. These isolates are of particular interest
because they display striking differences in their level of virulence, as defined by their
epidemiological and population characteristics, as well as virulence in a mouse infection
model. The fact that the strain we defined as hyper-virulent using epidemiological studies
was also found to be hyper-virulent using the definition of a rapid onset of disease and death
in a mouse model is of itself an interesting, and in some ways counter-intuitive, result.  A
common and long-held view of pathogen evolution is that strains that rapidly kill their host
may be negatively selected because the opportunities for transmission to new hosts are
reduced.  However, it is recognized that natural selection can still favor these strains as long
as they possess a compensatory advantage, for example higher instantaneous transmissibility
rates or increased resistance to host defenses (Gordon et  al ., 2009).  Thus, it is possible that
this strain is able to overcome the selective disadvantage of rapid killing of the host via
mechanism(s) such as these.  We also recognize that because of the significant differences in
TB pathology between in-bred laboratory mice and humans (Ten Bokum et  al ., 2008) our
animal model results are not necessarily translatable to our epidemiological ones.
From a total of 1670 identified proteins, we applied very stringent criteria to select a minimal
observed difference threshold, and a total of 101 proteins were identified as being
significantly differentially abundant in either sample.  Our criteria are in accordance with the
reported accuracy of emPAI, which has been shown to have an error range close to
maximally a factor of 3 (Ishihama et  al ., 2005).  Those 101 proteins were clustered into 3
functional categories, as defined in the Tuberculist resource database (established by(Cole et
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al ., 1998; Lew et  al ., 2011)).  In addition, the remaining proteins not classified as
differentially abundant were also used to check the presence of proteins previously described
as virulence markers or factors.  For example, one of the well characterized genomic regions
associated with virulence is the phtiocerol dimycocerosates lipid (PDIM) locus.  Mutants
containing deletions of this locus were unable to multiply in mouse models (Lipsitch and
Moxon, 1997).  Some members of the PDIM family are sometimes linked to a
phenoglycolipids (PGL) molecule, and such glycolipids are found to be very characteristic of
highly virulent Beijing strains (Reed et  al ., 2004).  The genes that participate in PGL
synthesis and modification are located together within the PDIM locus.  In recent years, this
locus has been analyzed in detail and the functions of many of these genes determined (Apt
and Kramnik, 2009).  In this work we identified peptides representing proteins from 18 genes
of a total of 35 genes present in that locus.  From those, only 2 proteins (PpsA and FadD28)
were not observed in a 1:1 ratio, but still the calculated differences were below our stringent
threshold, being 2.5 fold and 2.8 fold over-represented respectively in the hypo-virulent
strain, showing that in principle, PDIM and PGL synthesis are expected to be similar in this
model.
In addition, our data show that proteins from functional category 1 (lipid metabolism) seem
to be over-represented in the hypo-virulent strain.  As discussed for PGL, lipids and
lipoproteins (Camacho e t  al ., 1999; Siméone et  al ., 2007) these proteins are believed to be
key factors for acquisition of virulence in the strains.  However, our data suggests that within
a highly virulent strain family, the reducing part of the lipid repertoire may represent further
steps in the evolution of virulence.  A possible explanation for this process is that changing
the repertoire of surface molecules may result in an enhanced ability of the pathogen to
escape host recognition.  This is corroborated by the fact that we observed that well described
immunogenic proteins, ESAT-6, Esx-like proteins and MPT51 (FbpD) (Geiman et  al ., 2004),
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were under-represented in the hyper-virulent M. t ubercul osi s strain.  Interestingly, ESAT-6
and Esx-like proteins are highly-abundant and well defined virulence factors in M.
t ubercul osi s , since the deletion of the RD1 region containing this gene result in loss of
virulence (Sun et  al ., 2004) as observed for the attenuated M. bovi s BCG strain (Mahairas et
al ., 1996).  Previously in our group, we determined that the Esx-like proteins had a minimum
1.0 mol% in the avirulent M. t ubercul osi s H37Ra strain and up to 7.0 mol% in M.
t ubercul osi s H37Rv (data not shown).  However, the hyper-virulent Beijing strain showed
only 0.23 mol%.  Nonetheless, it is important to note that, while in this study we analyzed
whole cell extracts, the decreased levels of ESAT-6 and Esx-like proteins in the hyper-
virulent strain may be a result of faster export of these proteins to the extracellular
environment.
Molecules involved in regulation of transcription (Functional category 9) could be main
factors regulating virulence in our model.  This could be particularly relevant because if a
single transcriptional regulator effects the expression of numerous genes (either directly or
indirectly) a large phenotypic effect could result from a minor genetic change.  Interestingly,
the relevance of these genes in pathogenesis is illustrated by examples where the inactivation
of genes encoding sigma factors (Parish et  al ., 2003b; Malhotra et  al ., 2004) or 2CR systems
(Sørensen et  al ., 1995; Kendall et  al ., 2007) causes attenuation of virulence i n vi vo .  On the
other hand, mutations or deletions in some of these 2CR systems also involve increased
virulence (Parish et  al ., 2003a).  Strikingly, this was shown for the regulon devR in mouse
models, while alteration in the same gene has opposite effects in other animal infection
models (Sørensen et  al ., 1995).  In addition, most of the gene targets for these transcriptional
regulators remain unknown up to the present date.  This further increases the challenge in
assessing the participation of regulons in virulence acquisition.  This type of knowledge is
essential, since some of these regulators might be involved in inducing or repressing
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immunostimulatory molecules (de Souza et  al ., 2008).  We identified 10 regulatory proteins,
9 of which were over-represented in the hyper-virulent strain.  Of these, only Rv3574 has
been investigated in-depth.  It represses the expression of an estimated 74 genes in M .
t ubercul osi s (Lewis et  al ., 2003), some of them involved in lipid metabolism.  It was shown
that deletion of Rv3574 leads to attenuation of virulence, which is in accordance with our
data.
In summary, our data shows that many of the well characterized factors such as devR , phoP
and others are equally abundant in our model and most probably do not participate in the
attenuation of virulence in this case.  However, our in depth proteomic analysis allowed us to
question that, while lipid metabolism may be an important feature when comparing Beijing
strains with other clinical M. t ubercul osi s isolates, such molecules may play a lesser role in
virulence within the Beijing strain itself.  In addition, we identified several transcriptional
regulators that may play a role in virulence. Our results illustrate the full potential of a
proteomic approach to select promising candidate molecules and genes for further
characterization using the tools of molecular biology.
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CHAPTER 5
Label-free quantification of the proteome of the closely related hypo- and hyper-
virulent M. tuberculosis strains using MaxQuant analysis tool
My contribution to this project: Culturing of M. tuberculosis strains
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Data analysis
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5.1. Aim:
Here we used latest state of the art Q Exactive mass spectrometer in combination with the
MaxQuant label-free proteomics approach to compare whole cell lysate protein abundance
between two closely related M. t ubercul osi s Beijing genotype strains which demonstrate
different levels of virulence. Furthermore, we highlight how the use of various label-free
quantitation methodologies influences our interpretation of large scale proteome data.
5.2. Results and discussion:
Label-free quantification of whole cell lysate proteins in the hypo- and hyper-virulent
clinical M. tuberculosis Beijing strains
For an in depth proteomic characterization of whole cell lysate proteins in the hypo- and
hyper-virulent M. t ub er cul osi s Beijing strains, we adopted a strategy which included the
analysis of the whole proteomes of both strains (figure 5.1)
Figure 5.1: Workflow of the quantitative proteomics
Stellenbosch University  http://scholar.sun.ac.za
66
For the in depth analysis of the total proteome, whole cell lysates of the hypo- and hyper-
virulent M. t ubercul osi s Beijing strains were fractionated by SDS-PAGE (figure. 5.2).  For
our comparative analysis of these proteomes we used the mass spectrometry data obtained
from the resulting 60 LC-MS/MS files (30 files for the hypo-virulent strain and 30 files for
the hyper-virulent strain) in MaxQuant.  The intensity based absolute quantification (iBAQ)
algorithm was used to normalise the summed peptide intensities by the number of the
theoretically expected peptides of the protein (Schwanhäusser et  al ., 2011). Using these
analysis methods we identified a total of 2790 proteins which were present in both strains.
Figure 5.2: Fractionation of whole cell lysate protein using 4-12% SDS PAGE. A) Protein marker ~ 10 to
160 kDa. B) The whole cell lysate fraction of the hypo-virulent M.  tu b e rc u lo sis strain. C) The whole cell lysate
fraction of the hyper-virulent M.  tu b e rc u lo sis strain.
In total we obtained 70% protein coverage of the expected M. t uber cul o si s proteome in one
single experiment.  To date this is the largest proteome reported for clinical M. t ubercul osi s .
The total iBAQ normalized intensities of the identified proteins of each strain were
distributed across 6 orders of magnitude (figure. 5.3A), and when plotted against each other
present a Pearson correlation of R=0.9755 (figure. 5.3B), showing the high similarity
between the proteomes of each strain. All together, the Perseus software for statistical
analysis identified 703 differentially abundant proteins based on t-test with a permutation-
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based FDR threshold value of >0.01 based on the iBAQ normalised intensities (see
Appendix). Figure 5.3C demonstrates a volcano plot of the average iBAQ ratio (hyper/hypo
virulent) as a function of the t-test p-values.
Figure 5.3: Quantitative analysis of the proteome of the hypo- and hyper-virulent clinical M. tuberculosis
Beijing strains. A) Distribution of the total iBAQ normalized intensities. B) Plot correlation between hypo-
(507) and hyper- (5527) virulent strains, inset the Pearson coefficient of correlation ( R ). C) Volcano plot of the
average iBAQ ratio hyper/hypo virulent as a function of the t-test p-values. The Rv numbers demonstrate
several of the proteins that were not identified using the emPAI label-free quantitation analysis tool.
Among the differential proteins, 565 were significantly abundant in the hyper-virulent M .
t ubercul osi s Beijing genotype strain while 138 were significantly abundant in the hypo-
virulent M. t ubercul osi s strain. Figure 5.3C also demonstrates some of the proteins that were
not identified with the exponentially modified protein abundance index (emPAI) analysis
(Chapter 4).
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The over-abundant proteins were grouped according to their functional categories as given in
Tuberculist (figure. 5.4) (http://tuberculist.epfl.ch/) (Cole et  al ., 1998; Lew et  al ., 2011).
Proteins in the functional groups 0 (virulence, detoxification, adaptation), 1 (lipid
metabolism), 2 (Information pathways), 7 (Intermediary metabolism and respiration), 9
(regulatory proteins) and 10 (Conserved hypothetical proteins) were significantly over-
represented in the hyper-virulent M. t uber cul osi s strain (z-test;
p<0.05).
Figure 5.4: Functional categories of the differentially abundant proteins in the hypo- and hyper-virulent
M. tuberculosis strains according to Tuberculist (http://genolist.pasteur.fr/tuberculisy/). Asterisks represent
statistical significance using the z-test ( p <0.05).
Proteins involved in lipid metabolism, information pathways and intermediary metabolism
and respiration can inter-regulate the various biological processes.  These proteins are unique
since they form a biological network of processes, including lipid metabolism, glycolysis,
gluconeogenesis, synthesis and modification of macromolecules as well as protein/peptide
secretion (Mawuenyega et  al ., 2005).
We employed a stringent criteria threshold of 2 fold change based on the average iBAQ
intensities to define the most abundant proteins in order to identify proteins that could
contribute to our understanding of how altered gene expression and protein abundance could
contribute to the variation in phenotype of these two closely related M. t ubercul osi s strains.
Amongst the most differentially abundant proteins three hypothetical proteins were
significantly (P-value <0.01 and greater than 10 fold) over-abundant in the hyper-virulent
Stellenbosch University  http://scholar.sun.ac.za
69
strain. The conserved hypothetical protein Rv1894 demonstrated a 129.7 fold increase in the
hyper-virulent M. t uberc ul osi s strain and when searched against the bacterial bioinformatics
resource centre, PATRIC (PathoSystems Resources Integration Centre) (Snyder et  al ., 2007;
Gillespie et  al ., 2011) corresponded to locus tag VBIMycTub87468_2114 which encode for
2-nitropropane dioxygenase and is involved in nitrogen metabolism. The conserved
hypothetical protein Rv2840c showed an 11.7 fold increase in the hyper-virulent strain and
when search against PATRIC (Snyder et  al ., 2007; Gillespie et  al ., 2011) it corresponded to
locus tag VBIMycTub87468_3167 which encodes for the a gene product that is a predicted
nucleic-acid-binding protein which is implicated in transcription termination. The gene
product of Rv2570 has not been investigated for a probable function.
Sixty-six proteins involved in lipid metabolism were over represented in the hyper-virulent
strain. The PDIM locus is a well characterised genome region associated with virulence and
is involved in cell envelope trafficking suggesting that it is involved pathogenicity (Camacho
et  al ., 2001; Astarie-Dequeker et  al ., 2009). The PDIM locus has been analysed for its
involvement in the conditioning of the mycobacterial cell wall.  Previous studies have shown
that an avirulent H37Rv M. t ubercul osi s strain coated with a PDIM were able to persist
longer than the uncoated H37Rv M. t ubercul osi s strain, i n vi vo ( Kondo and Kanai, 1974;
Camacho et  al ., 2001). Furthermore, it has been shown that mutants containing deletions of
genes in this locus have a growth defect in the lungs of intravenously infected mice in
comparison to the wild type parental strain (Camacho et  al ., 1999). In our study Rv2934
(PpsD) and Rv2937 (DrrB) which are part of the PDIM locus were significantly over-
represented (p-value <0.01). PpsD which is a type-I modular polyketide synthase responsible
for the synthesis of the lipid core common to pthtiocerol dimycocerosates (DIM) and PGL
were 23.8 times more abundant in the hyper-virulent strain.  The integral membrane protein
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DrrB is an ABC transporter implicated in the efflux of daunorubicin DIM and was 4.6 times
more abundant in the hyper-virulent strain (Schwab et  al ., 2009).
Two esat-6-like proteins Rv1793 (EsxN) and Rv1038 (EsxJ) were over-represented, 2.59 and
2.12 fold respectively, in the hyper-virulent M. t ubercul osi s strain. The ESX-5 secretion
system which is the most recently evolved ESX system is responsible for the secretion of
EsxN (Houben et  al ., 2012).  In a recent study, mutants were generated in order to
demonstrate the involvement of the ESX-5 secretion system in the export of PPE/PE
transport and virulence. They demonstrated that the disruption of the ESX-5 system leads to
loss of PPE secretion, the reduction of cell wall integrity and strong attenuation of virulence
M. t ubercul osi s .  Furthermore they hypothesise that the attenuation might not be due to the
inactivation of the EsxN but rather due to the alteration in the integrity of the mycobacterial
cell wall (Bottai et  al ., 2012).
Our comparative label-free quantitative analysis of the proteome of the two clinical M.
t ubercul osi s Beijing strains also revealed a number of differentially abundant proteins
involved in the main protein biosynthesis and glucose metabolism pathways, including the
tricarboxylic acid cycle (TCA) and glycolysis/gluconeogenesis that were significantly (p-
value <0.01) over represented in the hyper-virulent strain (Table 5.1).
Here we show proteins involved in glycolysis and the TCA cycle were over represented in
the hyper-virulent M. t ubercul osi s strain suggesting that this strain could be a better
scavenger of carbon. M . t ubercul osi s can utilise carbon from various sources i.e. (1) fatty
acids produced during lipid metabolism, (2) amino acid biosynthesis and (3) glucose (Griffin
et  al ., 2012).
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Table 5.1: Proteins involved in central carbon metabolism according to PATRIC
(http://www.patricbrc.org/) and Kyoto Encyclopedia of Genes and Genomes (KEGG)
(http://www.genome.jp/kegg/pathway.html) which were over-represented in the hyper-virulent M.
tuberculosis Beijing strain.
Rv number Protein name
Protein
P-value$ Fold change*
Rv0946c Glucose-6-phosphate isomerase 1.7E-4 1.22
Rv1436 Glyceraldehyde-3-phosphate dehydrogenase 0.005 1.15
Rv1475 Aconitate hydratase 9.21E-5 1.28
Rv1098c Fumarate hydratase 0.001 1.17
Rv2332 Malate dehydrogenase 0.004 2.20
*Calculated ratio using average iBAQ intensities
$ Calculated using Perseus
It has previously been shown that strains with the M. t ubercul osi s Beijing genotype may have
a duplication in the DosR regulon.  The DosR regulon regulates several genes involved in
lipid metabolism and respiration (Voskuil et  al . 2004; Reed et al ., 2007; Domenech et  al .
2010). According to the proteomics data of the current study, several protein products of the
DosR-dependant genes were over-represented (p-value <0.01) in the hyper-virulent M.
t ubercul osi s strain (Table 5.2). A preliminary PCR analysis suggests that the 350 kb DosR
duplication is absent in the hypo-virulent strain (data not shown).
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Table 5.2: DosR-dependant genes products over-represented (p-value <0.01) in the hyper-virulent strain
Rv number Gene Predicted function Fold change*
Rv1177 fd x C Ferredoxin 1.5
Rv1738 - Conserved hypothetical protein 2.2
Rv1955 h ig B Regulatory role 100.6
Rv1996 - Response to stress 1.8
Rv2005 - ATP binding and response to stress 1.6
Rv2007 fd x A Ferredoxin and transport 2.3
Rv2030 - Nucleoside metabolic process 1.4
Rv2031 h sp X Alpha crystalin 1.8
Rv2032 A c g Dinucleotide-utilizing enzyme 1.6
Rv2632 - Conserved hypothetical protein 1.4
Rv3143 - Response regulator 1.2
*Calculated using average iBAQ intensities
In a recent metabolomics study of the hypo and hyper-virulent M. t ubercul osi s strains,
metabolite markers associated with virulence phenotype were identified, suggesting an
increase in metabolic activity and subsequently leading to increase in growth rate which in
turn all can contribute to the ability of the hyper-virulent M. t ubercul o si s Beijing strains’
increased virulence and pathogenesis (Meissner-Roloff et  al ., 2012). We propose that an
increased expression of proteins involved in the lipid and energy metabolism pathways
together with other enzymes taking part in intermediate metabolism could suggest a higher
intermediary metabolic activity leading to an increase in growth rate as was for the hyper-
virulent strain i n vi vo which can be associated with increased virulence.
A direct correlation between the proteome and genome of the two strains is not obvious
(Table 5.8).  However, the presence of an nsSNP in the w hi B7 gene in the hypo-virulent
strains suggests that the function of this global regulator may be impaired.   This together
with the absence of a copy of the DosR regulon suggests major alterations in the biology of
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the hypo-virulent strain thereby possibly explaining its mild pathology in the mouse model
(Reed et  al ., 2007).
Table 5.3: Presence and absence of SNP in hypo- and hyper-virulent M. tuberculosis strains
Strain SNP/indel Rv number (annotation) Protein abundance
LV 4bp del Rv0070c n.s
LV prob. IS insertion Rv0095c n.s
LV SNP Rv0278c n.s
LV 2SNP Rv0278c n.s
LV SNP Rv0580c 1.012
LV 3SNPs Rv1223 n.s
LV SNP Rv1384 1.018
LV SNP Rv1450c n.s
LV SNP Rv1793 1.051
LV Ins Rv1894c n.s
LV SNP Rv1917c n.s
LV SNP Rv1948c n.s
LV SNP Rv1963c; n.s
LV SNP Rv2316 n.s
LV SNP Rv2543 n.s
LV SNP Rv3197A n.s
LV SNP Rv3347c n.s
LV SNP Rv3425 n.s
HV SNP Rv0213c n.s
HV SNP Rv0214 0.883
HV SNP Rv0430 0.984
HV SNP Rv0753c 1.015
HV SNP Rv0777 n.s
HV SNP Rv0988 n.s
HV SNP Rv1226c n.s
HV SNP Rv2134c 1.033
HV SNP Rv2664 n.s
HV SNP Rv2687c n.s
HV SNP Rv3542c n.s
LV- hypo-virulent M. tuberculosis strain
HV– Hyper-virulent M. tuberculosis strain
n.s – Not significant
This study also highlighted how the use of different methodologies for label-free proteomics
analysis and mass spectrometry instruments could impact on the interpretation of results.
Analysis of the total proteomes of the hypo- and hyper-virulent strains using the Q Exactive
instrument, which has a higher sensitivity and specificity than the LTQ Orbitrap XL
instrument (Michalski et  al ., 2011), resulted in the identification of 1146 additional proteins
when compared to the emPAI analysis. The emPAI method is based on the rate of
identification of peptide/protein in the mass spectrometer, assuming that the more abundant a
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protein within a sample, the better the sequence coverage of the protein characterization.
Therefore, emPAI estimates the protein abundance in a sample using a ratio derived from the
number of observed peptides divided by the number of theoretical peptides of a specific
protein.  However, as mentioned its quantitation relies on peptide identification and specific
chemical weight features, and thereby tends to overestimate the quantities of low molecular
weight proteins.
The proteomics data that is presented in this chapter were obtained by using an Area Under
Curve (AUC) approach, where chromatographic elution features of each peptide measured by
the Q Exactive and peptide peak intensities are calculated by MaxQuant.  Furthermore,
MaxQuant uses the accurate mass and retention time between runs for protein quantification
which means that it is less influenced by proteins size.
Figure. 5.5: Venn diagram of comparison of over-abundant proteins using LTQ-Orbitrap combined with
emPAI versus Q Exactive combined with MaxQuant of hypo- and hyper-virulent M. tuberculosis strains.
Even though both label-free quantitative analysis software tools (emPAI and MaxQuant)
provide useful information we demonstrate here that by using a more sensitive mass
spectrometer, the Q Exactive in combination with MaxQuant analysis.  The difference
observed in results between the two approaches (Chapter 4 and Chapter 5) is probably
because the latest proteomics technology, Q Exactive, is more sensitive and can perform
more peptide sequences per second than the Orbitrap XL used in the previous analysis of the
hypo- and hyper-virulent strains (Chapter 4) (de Souza et  al ., 2010). Furthermore, weaker
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statistical value was added to the emPAI data analysis tool (Chapter 4) while the MaxQuant
data analysis package can be used in combination with the Perseus tool to incorporated
statistical value to the identification of differentially abundant proteins.  Therefore, the
differentially abundant proteins calculated in MaxQuant are much more reliable.  When we
compared the over-abundant protein identified using both methods (Chapter 4 and 5) we
identified 679 more over-abundant proteins using MaxQuant (figure 5.5).  In addition to the
differences observed we cannot exclude that the protein extracts of whole cell lysate proteins
from the hypo- and hyper-virulent strains analysed for the two approaches were done on two
separate occasions.
In summary, here were present the largest quantitative proteome for M. t u bercul osi s to date.
Furthermore we have identified numerous factors that might alter metabolic pathways of the
hyper-virulent strain to adapt to survive over a longer period within the host and contribute to
the attenuation the virulence phenotype of the transmitting M. t uberc ul osi s strain.  For
example, we show an increase abundance of proteins involved in biosynthesis pathways of
several carbon sources, i.e. lipid metabolism, central carbon metabolism
(glycolysis/gluconeogenesis and TCA cycle), and amino acid biosynthesis that the
mycobacterium bacilli can for energy production.
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CHAPTER 6
The phosphoproteome of closely related hypo- and hyper-virulent
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6.1. Aim:
The aim of this study was to use a proteomics approach (LTQ-Orbitrap-Velos combined with
MaxQuant label-free proteomics) to identify and characterise the phosphoproteome of the
two closely related hypo- and hyper-virulent clinical M. t ubercul osi s Beijing strains with the
view to determine the possible role of phosphorylation in pathogenesis.  In order to
understand the biology and pathogenic mechanisms of M. t ubercul osi s it is relevant to
establish which proteins are phosphorylated at the whole proteome level which could identify
metabolic pathways associated with virulence and pathogenesis.
6.2. Results and discussion:
Identification of phosphorylated proteins in the hypo- and hyper-virulent clinical
M.tuberculosis Beijing strains
Whole cell lysate proteins were extracted from the hypo and hyper-virulent M. t ubercul osi s
strains (described in chapter 4 and 5) cultured in Middlebrooks media supplemented with
catalase and dextrose at midlog growth phase (OD600 of 0.7).  Phosphorylation states were
preserved with the addition of phosphatase inhibitors.  Four milligram whole cell lysate
proteins from each strain were processed using the FASP method and technical triplicates
hypo-and hyper-virulent strains was generated for further analysis (Wiśniewski et  al ., 2009)
demonstated in figure 6.1.
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Figure 6.1: Workflow of the quantitative phosphoproteomics
LC-MS/MS enabled the identification of a total of 718 (S/T/Y) phosphorylation sites present
on 620 peptides.  These peptides mapped to 286 “phosphorylated” proteins (Appendix Table
6.1).  This compared favourably with the most extensive data set on Ser/Thr phosphorylation
available for M. t ubercul osi s where a slightly higher number of phosphorylated proteins were
identified for H37Rv compared to the current study of clinical M. t uber cu l osi s (301 vs. 266).
Interestingly only 98 phosphorylated proteins were identified in both studies which may
reflect both differences in the approaches used to increase the identification of
phosphorylated proteins. Pooled data from six different growth conditions (Prisic et  al .,
2010) were used while the phosphoproteome presented in the current study represents only
one growth condition, midlog growth phase, and we identified more phosphorylated peptides
and phosphorylation-sites (Table 6.2).  Most of the identified phosphorylated peptides (73%)
showed the presence of a single phosphorylation site, while the remaining peptides (23%)
showed phosphorylation at two sites.  Phosphorylated peptides with >2 phosphorylation sites
were not identified (figure 6.2B).
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Table 6.1: Comparative phosphoproteome profile of the previously described H37Rv M.tuberculosis and
both the clinical M. tuberculosis Beijing from the current study.
Variable Prisic et al.,
2010
Current
study
Hypo-virulent
M. tb
Hyper-virulent
M. tb
No. of Phosphorylated proteins 301 286 95 191
No. of Unique Phosphorylated
peptides
381 620 185 435
No. of Phosphorylation events 516 718 218 500
Phosphorylated serine 40% 43.0% 101 208
Phosphorylated threonine 60% 53.4% 106 278
Phosphorylated tyrosine 0% 3.5% 11 14
Of the 286 phosphorylated proteins 70 were uniquely identified in the hypo-virulent strain and 166 in
the hyper-virulent with just 28 were that were common to both strains (figure 6.2A).  We observed the
site of phosphorylation on Ser/Thr/Tyr with the ratio being 101:106:11 for the hypo-virulent and
208:278:14 for the hyper-virulent strain respectively.  Not surprisingly, the distribution of serine,
threonine and tyrosine is in accordance with previously described phosphoproteome of other
prokaryotes (Macek e t  al ., 2007). We acknowledge that the over-representation of phosphorylation
sites in the hyper-virulent strain might be due to technical limitations of the study and only represents
a snapshot taken during midlog growth phase of two strains with varying levels of virulence.  If these
growth conditions might change numerous other phosphorylation sites may be detected and could
possibly lead to an overlap of phosphorylation sites during various growth conditions.
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Figure 6.2: The phosphoproteome of the hypo- and hyper-virulent clinical M.tuberculosis Beijing strains.
A) Phosphorylated protein identification. B) Distribution of phosphorylation across the identified peptides.
The MS/MS spectra of a representative phosphopeptide LGIPQIpSTGELFR from protein
Rv0733 (adk ) is demonstrated in figure 6.3 (where pS is phosphoserine).  This adenylate
kinase is a small ubiquitous enzyme essential in intracellular nucleotide metabolism.  It has
also been shown that this protein acts as both a nucleoside mono- and diphosphate kinase and
could be implicated in RNA and DNA biosynthesis (Meena et  al ., 2003).
Figure 6.3: MS/MS spectra of the serine phosphorylated peptide LGIPQIpSTGELFR from protein
Rv0733 (adk)
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This is the first study to identify phosphorylated tyrosine in M. t ubercul osi s . The detection of
tyrosine phosphorylation using mass spectrometry is normally limited due to its low
abundance (Macek and Mijakovic, 2011).  Most bacterial phosphorylation sites are on serine
(70%) and threonine (20%) while tyrosine phosphorylation events account for less than 10%
of the overall phosphoproteome (Macek and Mijakovic, 2011) while serine- and threonine
phosphorylation account for 43% and 53.4% respectively. Tyrosine phosphorylated proteins
have been previously shown to play important regulatory roles through their involvement in
exopolysaccharide production, virulence, DNA metabolism, stress responses amongst other
biological functions of the bacterial cell (Kobir et  al ., 2011).  Furthermore, the level of
tyrosine phosphorylation appears to have a positive correlation with the pathogenicity (Ge
and Shan, 2011).  In this study, 3.5% of the phosphorylated peptides were tyrosine
phosphorylated peptides (Table 6.2).  We identified 14 tyrosine phosphorylation sites in 10
phosphorylated proteins in the hyper-virulent strain relative to the 8 phosphorylation sites in
4 phosphorylated proteins in the hypo-virulent strain.  Six of the tyrosine phosphorylated
proteins identified in the hyper-virulent strain were essential genes for i n vi t ro growth
(Sassetti and Rubin, 2003; Griffin et  al ., 2011).  One of these essential genes Rv0440
(GroEL2) were also amongst the tyrosine phosphorylated proteins.  GroEL2 is involved in
the prevention of misfolding and promotes refolding and the proper assembly of unfolded
polypeptides that is generated under stress conditions.  Another tyrosine phosphorylated
protein identified in the hyper-virulent strain is gl n A1 which has been implicated in glutamine
synthesis and is the only class I glutamine synthase gene that is essential for M. t ubercul osi s
growth(Harth e t al ., 2005).  It has been shown that the disruption if gl nA1 in M. t ubercul osi s
result in glutamine auxotrophy where the mycobacteria cannot synthesize glutamine and
could have implications on the amino acids biosynthesis.  It has also been shown that this
enzyme are released into the culture also plays a crucial role in pathogenesis (Harth et  al .,
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2005). Multiple tyrosine phosphorylated peptides were identified for proteins Rv0020c
(fhaA) which is one of the 6 fha-domain containing proteins in M. t ub ercul osi s .  FhaA is a
regulatory protein and have been implicated in cell wall biosynthesis (Fernandez et  al ., 2006)
and has a strong association with PknA and PknB (Pallen et  al ., 2002; Roumestand et  al .,
2011).
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Table 6.2: Tyrosine phosphorylated proteins identified
Rv number Gene name Functional category Protein function Strain Tyrosine phosphorylated peptide
Rv0001 d n a A F2 DNA replication initiation, regulation of DNA
replication, ATP-binding
HV _GDNQHSWPSpYFTERPHNTDSATAGVTSLNR_
Rv0020c fh a A F9 Conserved hypothetical protein with FHA
domain
LV _HEEGSpYVPSGPPGPPEQR_
LV _HPDQGDpYPEQIGYPDQGGYPEQR_
LV _HPDQGDYPEQIGpYPDQGGYPEQR_
LV _VPGpYAPQGGGYAEPAGR_
HV _GGYPPETGGYPPQPGpYPRPR_
HV _QDpYGGGADYTRYTESPR_
HV _(gl)QDYGGGADpYTR_
HV _GGQGQGRPDEpYYDDR_
HV _GGQGQGRPDEYpYDDR_
Rv0312 - F10 Proline and threonine rich protein, ATP-binding HV _FEGDpSYNEGGPCWSM(ox)R_
Rv0421c - F10 Conserved hypothetical protein HV _GLAEGPLIAGGHpSpYGGR_
Rv2198c mmp S 3 F3 Integral membrane protein HV _AYpSAPESEHVTGGPpYVPADLR_
HV _ASGNHLPPVAGGGDKLPSDQTGEpTDApYSR_
Rv0632c e c h A 3 F1 Probable Enoyl-CoA hydratase HV _pSDPVSYTR_
Rv0440 g ro E L2 F0 60 kDa Chaperonin 2 HV _(gl)QEIENSDSDpYDREK_
Rv0613c - F10 Conserved hypothetical protein HV _IVLAGpYDEELLER_
Rv1513 - F10 Conserved hypothetical protein HV _HQDAFPPANpYVGAQR_
Rv2220 g ln A 1 F7 Glutamine synthase HV _DLpYELPPEEAASIPQTPTQLSDVIDR_
Rv3147 n u o C F7 NADH-ubiquinone activity, transport HV _GM(ox)FGVpSGTGDTSGYGR_
Rv3398c id sA 1 F1 Probable multifunctional geranylgeranyl
pyrophosphate synthase
HV _pYGLPPQPDSDR_
Rv3628 p p a F7 Inorganic diophosphatase activity, Magnesium
ion binding
HV _HFFVHpYK_
LV- hypo-virulent M. tuberculosis strain
HV– Hyper-virulent M. tuberculosis strain
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All the 286 phosphorylated proteins identified in the hypo- and hyper-virulent strains were
grouped into their functional categories accoding to Tuberculist (Cole et  al ., 1998; Lew et  al .,
2011) (figure. 6.4).  The functional distribution of these phosphorylated proteins shows an
over-representation in most of the functional groups in the hyper-virulent M. t ubercul osi s
Beijing strain suggesting a relationship between post-translational regulation and virulence.
Figure 6.4: Functional categorisation of phosphorylated proteins according to Tuberculist. Asterisks
represent statistical significance (p<0.05).
In order to verify whether the identified phosphorylation events were post-translationally
regulated, we compared the RNA expression of 7 of the 11 STPK’s encoded by the M.
t ubercul osi s genome.  RNA abundance of the seven autophosphorylated STPK’s were
analysed by qRT-PCR.  Figure 6.5 shows a virtual electrophoretic fractionation of purified
RNA isolated on separate days.  The RNA extractions was considered acceptable further
analysis given the presence of the dominant 16S and 23S rRNA species, the A260/A280 ratio
being between 1.8 and 2.1 and no high molecular weight DNA was visible.
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Figure 6.5: Assessment of RNA quality by a virtual gel (Experion software-BIORAD)
From Table 6.3 it is evident that there is no significant difference in the levels of RNA
expression of the respective kinases based on the ratio of relative abundance of the protein
abundance (chapter 5) and phosphorylated proteins identified (described in this chapter) in
the hypo-and hyper-virulent strains.  This contrasts with the over-abundance of the
phosphorylated form of PknD (14.6 fold) and PknF (5.9 fold) in the hyper-virulent strain.
23S rRNA
16S rRNA
tRNA
4Marker 1 2 3
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Table 6.3: Ratio of non-phosphorylated (average iBAQ ratio) and phosphorylated (average intensities) and relative expression of 7 STPKs
Rv number Gene name Strain Proposed regulatory role Average iBAQ ratio non-phosphorylated protein
Average intensity ratio
phosphorylated protein Relative level of transcription
Rv0015c Pk nA HV Cell elongation and division 0.9 1 n.s
Rv0014c Pk nB HV Cell elongation and division 0.9 2.3 n.s
Rv0931 Pk n D HV Phosphate transport 1.1 14.6 n.s
Rv1743 Pk nE HV Membrane transport 1.7 not in hypo-virulent M. tb n.s
Rv1746 Pk nF HV Membrane transport 0.4 5.9 n.s
Rv0410c Pk n G LV, HV Amino acid uptake, stationary phase
metabolism
1.1 0.5 n.s
Rv2176 Pk n L HV Transcription 0.4 0.4 n.s
LV- Hypo-virulent M.tuberculosis strain –
HV- Hyper-virulent M.tuberculosis strain –
n.s –not significant
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Seventeen proteins identified with the highest confidence of identification (based on p-value
<0.05 and peptides identified in at least 2 technical replicates) were further investigated.
Twelve of these phosphorylated proteins identified in the hyper-virulent strain were also
identified in the H37Rv phosphorylome in a variety of conditions (Prisic et  al ., 2010).
Amongst them, the Rv0503 and Rv2606c, involved in lipid metabolism and intermediary
metabolism and respiration, were identified during stationary phase.  Rv2606c encodes for
pyridoxal biosynthase lyase (Pdx1/SnzP/PdxS), involved Vitamin B6 biosynthesis and is
essential for the survival (Dick et  al ., 2010) and has been implicated in the virulence of M.
t ubercul osi s .  Bacteria that have the ability to utilise pyridoxine pathway can use carbon
source providing a precursor for the tyrosine synthesis pathway
((http://umbbd.ethz.ch/pdi/pdi_map.html) Biocatalyst/Biodegeration database, University of
Minnesota).  The protein Rv0503 has not been investigated for its functional role.
Furthermore, 7 phosphorylated proteins that were identified in the hyper-virulent strain were
identified in H37Rv when it was grown in acetate as a carbon source (Prisic et  al ., 2010),
suggesting that the hyper-virulent strain has the ability or has adapted to utilise carbon and
other sources.
In our study we also identified the ATP transporter (Rv1747) and STPK (PknF) that have
previously been shown to be involved in the transport of glucose across the membrane (Deol
et  al ., 2005).  PknF and Rv1747 are membrane proteins transcribed from in the same operon
(Curry et  al ., 2005). Both of these proteins (in their phosphorylated state) were identified in
the hyper-virulent M. t ubercul osi s strain with high confidence; PknF showed a 5.9 fold
increase while Rv1747 showed a 2.3 fold increase based on the ratio of their average
intensities.  PknF interact with its substrate Rv1747 via a phospho-specific interaction
(Spivey et  al ., 2011). Rv1747 has also been characterised as an efflux pump and has also
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been implicated in rifampicin resistance (Louw et  al ., 2011). Rv1747 is also the substrate for
4 of the 11 M. t ubercul osi s STPK’s, i.e. PknB, PknD, PknE and PknF (Grundner, et  al .,
2005). Importantly, Rv1747 contain 2 of the 7 Forkhead-associated (FHA) domains encoded
by the 6 FHA domain containing proteins in the M. t ubercul osi s genome.  FHA domains are
phosphopeptide recognition motifs spanning 80-100 amino acid residues that is folded in an
11-stranded beta sandwich which recognises and mainly binds phospho-threonine residues in
specific peptides or proteins (Nott et  al ., 2009). Most FHA domains recognise phospho-
threonine with specificity provided by residues C-terminal to the phospho-threonine residue,
particularly the +3 position.  PknF interacts with the phosphorylation sites at Thr-150 and
Thr-208 of Rv1747 in order to exhibit ATPase activity to perform in the uptake of glucose
(Molle et  al ., 2004).  It has previously been shown that Rv1747 is required for virulent
infection by M. t ubercul osi s in mice (Curry et  a l ., 2005). We propose that an increase in
uptake of glucose could lead to an increased metabolic activity of the cell which may be
associated with hyper-virulence.
The autophosphorylated PknD was also identified in the hyper-virulent strain.  It has been
previously shown that increasing PknD activity in M. t ubercul osi s resulted in the specific
phosphorylation of a single anti-anti-sigma factor homolog, Rv0516c (Greenstein, MacGurn,
et  al ., 2007). Even though the phosphorylated form of Rv0516c was not identified, the non-
phosphorylated protein was over represented in the hyper-virulent strain (chapter 5).
Only four proteins (Rv0458, Rv0178, Rv0813 and Rv3799) containing phosphorylated
peptides were uniquely identified with high confidence (based on P-values <0.05) in the
hyper-virulent M. t uber c ul osi s strain.  Three of these proteins have been implicated in lipid
metabolism while Rv0178 (mce-associated membrane protein) in the mce operon 1 ( mc e1 )
and has directly been implicated in virulence (Casali et  al ., 2006).
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Whole genome sequencing of the two closely related strains, the hypo- and hyper-virulent M.
t ubercul osi s strains revealed 51 non-synonymous single nucleotide polymorphisms (nsSNP)
were identified in the two strains (data not published). The SNPs identified with high
confidence in either the hypo- and hyper-virulent strain with the highest confidence is given
in table 5.3.  Amino acid changes in genes that are involved in regulatory function, or that are
part of the upstream signal transduction pathways were significantly over represented among
the SNP’s that were intragenic and fixed in the typical Beijing lineage.  Numerous biological
processes in bacteria are regulated by transcription and these changes in the regulatory
networks are thought to significantly contribute to phenotypic diversity (Perez et  al ., 2009).
It has previously been shown that strains of the W/Beijing show up-regulation of the DosR
regulon which is also responsible for the regulation of various genes involved in lipid
metabolism (Reed, 2007).  Proteins involved in DNA transcription was observed in the
hyper-virulent strain when compared to the hypo-virulent strain (described in chapter 4) (de
Souza et  al ., 2010). A double mutation identified in the PknA sensor domain which has
shown to be crucial in the response to signals (Thakur et  al ., 2008) and also contributes to the
specificity of the kinase.  Strikingly PknA was also found to be phosphorylated and was
identified with high confidence (peptides identified by MS/MS in two technical replicates) in
the hyper-virulent strain.  Furthermore, an amino acid mutation was also identified in the
response regulator KdpE which is also crucial in responding to signals.  Interestingly, the
sensor kinase of this two-component system KpdD was found to be phosphorylated in the
hyper-virulent strain (Vlisidou et  al ., 2010). These mutations of the mycobacterial regulatory
network might have contributed to the alteration of cellular responses of these two strains to
environmental signals and lead to varying levels of virulence.
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In summary, we propose that the increased identification of phosphorylation events in the
hyper-virulent strain contributes to altered gene expression due to post-translational
regulation and contributes significantly to the phenotypic differences, i.e. varying level of
virulence, between these two closely related M. t ubercul osi s strains. Most importantly, we
believe that our dataset extend and complement the previous knowledge regarding the
phosphorylated peptides and phosphorylation sites. This depth phosphoproteomics analysis
of the hypo and hyper-virulent M.t uber cul osi s Beijing strains provide a novel tool to identify
and characterise proteins involved in various biological processes.  The identification of an
altered metabolic pathway in the hyper-virulent M.t ubercul osi s strain provides novel insight
into understanding virulence mechanisms.
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CHAPTER 7
Proteome analysis of a rifampicin mono-resistant M. tuberculosis strain and the
wild type progenitor strain
My contribution to this project: Culturing of M. tuberculosis strains
Protein extractions
Sample preparation for Mass Spectrometry analysis
Data analysis
Manuscript in preparation
Stellenbosch University  http://scholar.sun.ac.za
92
7.1: Introduction
Drug resistance in M y c obact eri um t ubercul osi s develops spontaneously and the resulting
drug resistant mutants are selected during periods of poor adherence, mono-therapy and the
administration of inappropriate treatment. In vi t ro studies analysing spontaneously generated
drug resistant M. t uber cu l osi s mutants have shown a direct correlation between mutations in a
specific target gene and resistance to the anti-tuberculosis (TB) drug used to select the
resistant mutants (Bobadilla-del-Valle et  al ., 2001).  Consequently, the relationship between a
defined mutation and resistance to a specific anti-TB drug has become a dogma and now
forms the basis for the development of molecular-based drug-resistance diagnostic assays
(Georghiou et  al ., 2012).  However, the above studies have failed to exclude the possibility
that additional modulatory mutations may occur concurrently in association with the
evolution of drug-resistance. Furthermore, it is not known whether mutation in certain target
genes could influence the transcriptome/proteome. Non-synonymous single nucleotide
polymorphisms (nsSNPs) conferring RIF resistance occur exclusively in the rpoB gene, with
95% occurring within the 81bp region known as the RIF resistance-determining region
(RRDR) (Telenti et  al ., 1993). Generally, these snSNPs result in the replacement of aromatic
amino acids with non-aromatic amino acids causing drug resistance by altering the forces that
bind RIF to the RNA polymerase (Campbell et  al ., 2001). Furthermore, amino acid
substitutions in the essential ß-subunit of RNA polymerase are thought cause alteration in the
expression of genes in RIF resistant strains leading to subsequent changes in various
metabolic pathways (Du Preez and Loots, 2012).
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7.2. Aim:
In this study we aimed to determine whether the i n  vi vo emergence of RIF resistance altered
protein abundance in a clinical isolate of M. t uber cul osi s , with the view to determine the
impact of RIF resistance on the physiology of the bacilli.  We used a proteomic approach
which combined the latest state of the art mass spectrometer (Q Exactive) with the label-free
data analysis tool MaxQuant to perform a quantitative proteomics analysis of a RIF-mono-
resistant mutant and wild type parent M. t ub er cul o si s strain.
7.3. Results and discussion:
7.3.1. Selection of RIF mono-resistant mutant and wild type M. tuberculosis progenitor
strains
DNA sequencing of the r poB gene of a RIF-mono-resistant clinical isolate demonstrated both
a wild type (TCG) and a mutant (TTG) codon at position 531, suggesting hetero-resistance.
Single colony forming units were selected in the presence and absence of RIF and the
respective rpoB genes were sequenced to identify resistant and susceptible strains.  Hetero-
resistance was confirmed by spoligotyping which demonstrated that both the RIF-mono-
resistant mutant and wild type progenitor M. t uber cul osi s strain were members of the Beijing
genotype (Kamerbeek et  al ., 1997).
7.3.2. Label free comparative quantification of proteomes of the M. tuberculosis Beijing
rpoB mutant and the wild type parent strain
Whole cell lysate proteomes extracted from the M. t ubercul osi s Beijing RIF-mono-resistant
mutant and the wild type progenitor strain were fractionated by gel-LC-MS/MS.  Label-free
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quantification of proteins was done using the MaxQuant software package; comparing the
levels of protein abundance between the RIF-mono-resistant mutant and the wild type
progenitor strain as described in Chapter 3 (figure 7.1).  A total of 90 LC-MS/MS files were
analyzed from 3 replicates of the RIF-mono-resistant mutant and wild type strain,
respectively.
Figure 7.1: Workflow of the proteome analysis of the RIF-mono-resistant mutant and the wild type
progenitor M. tuberculosis strain.
Figure 7.2 demonstrates a volcano plot of the average iBAQ ratio (described in Chapter 5) of
proteins extracted from the two strains as a function of their t-test p-values. Using this
algorithm we identified 2703 proteins present in both the RIF-mono-resistant mutant and the
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wild type progenitor strain.  Of these, 1885 (69%) proteins were present in equal abundance,
while 818 (31%) showed varying degrees of abundance.
Figure 7.2: Volcano plot of the average iBAQ for the RIF-mono-resistant mutant and the wild type
progenitor strain as a function of the t-test p-values. The spots in green indicate decrease in abundance, while
spots in red indicate proteins with an increased abundance after acquisition of the rp o B mutation.
From this data set we showed that the abundance of 189 proteins was significantly decreased,
while the abundance of 434 proteins was significantly increased as a consequence of the
evolution of RIF resistance [Perseus software for statistical analysis (unpublished) tool in
combination with t-test (FDR threshold set to a p-value of ≤0.01 – calculated from the
normalised iBAQ intensities (Chapter 5)]  Proteins with an increased abundance could be
grouped into 7 functional categories according to Tuberculist (Cole et  al ., 1998; Lew et  al .,
2011).
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Figure 7.3: Differentially abundant proteins of RIF-mono-resistant mutant compared to the wild type
progenitor strain according to the different functional categories. * indicates significant difference (z-test
P<0.05) between the two strains.
Proteins involved in virulence, detoxification and adaptation (functional category 0), lipid
metabolism (functional category 1), information pathways (functional category 2), cell wall
and cell processes (functional category 3), intermediary metabolism and respiration
(functional category 7), regulatory proteins (functional category 9) and conserved
hypothetical proteins (functional category 10) were significantly over-abundant in the RIF-
mono-resistant mutant. This suggests that the S531L rpoB mutation influences the regulation
of several biological processes including lipid metabolism, energy metabolism and amino
acid metabolism which all influences the mycobacterial cell wall composition.
Our comparative analysis showed that 8 significantly abundant proteins selected with the
Perseus-tool to be significant (p-value < 0.01) and had a 10 fold increase in the RIF-mono-
resistant mutant strain (Table 7.1).  Probable protein functions have been assigned to only 5
proteins (Rv1738, RsfB, MoaE2, VapC32 and AhpC); however these proteins have not been
investigated for their role in drug resistance.  The hypothetical protein Rv1738 is an essential
protein (Sassetti and Rubin, 2003) and its expression is regulated by the DosR regulon
(Bartek et  al ., 2009).
RsfB is one of 6 molecules with putative anti-sigma factor antagonist or stress signalling
proteins and is over-expressed during cold and oxidative stress (Dhandayuthapani, 2007).  In
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our dataset we also identified the probable molybdenym cofactor biosynthesis E2 (MoaE2)
protein which showed a 17.2 fold increase in abundance in the RIF-mono-resistant mutant. In
mycobacteria molybdenum enzymes are involved in the global carbon, sulphur and nitrogen
cycles which catalyse important redox reactions which have implications for several
biological functions including dormancy regulation (Shi and Xie, 2011).  The abundance of
the VapC32 protein was increased by 18.1 fold in the RIF-mono-resistant mutant and forms
part of the toxin-antitoxin systems which has been implicated in bacterial programmed cell
death (PCD) and persistence in stress conditions (Arcus et  al ., 2005).  It has been
hypothesised TA systems may be important for changing growth rate, inducing long term
dormancy and in generating bacilli that can survive multidrug chemotherapy (Dahl et  al .,
2003; Beste et  al ., 2009; Han et  al ., 2010; Frampton et  al ., 2012).  The abundance of the alkyl
hydroperoxide reductase C protein (AhpC) was increased significantly by 10.9 fold in the
RIF-mono-resistant mutant and has been shown to compensate for the catalase-peroxidase
deficiency caused by oxidative and nitrosative stress (Guimarães et  al ., 2005).
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Table 7.1: Eight significantly abundant proteins with (p-value < 0.01 and 10 fold increase) in the RIF-mono-resistant mutant strain
Protein IDs Gene name Essential/ Non-essential Protein description Functional category Ratio* p-value$
Rv1489 - Nonessential Conserved hypothetical protein F10 27.4 < 0.01
Rv1738 - Essential Conserved hypothetical protein F10 11.2 < 0.01
Rv1352 - Non-essential Conserved hypothetical prototein F10 10.0 < 0.01
Rv1117 - Non-essential Conserved hypothetical protein F10 10.0 < 0.01
Rv3687c rsfB Non-essential Anti-anti-sigma factor F2 17.8 < 0.01
Rv0866 mo a E 2 Non-essential Probable molybdenym cofactor biosynthesis E2 F7 17.2 < 0.01
Rv1114 v a p C3 2 Non-essential Conserved hypothetical protein with PIN domain F0 18.1 < 0.01
Rv2428 a h p C Non-essential Alkyl hydroperoxide reductase C protein F0 10.9 < 0.01
*Calculated using average iBAQ intensities
$Calculated using Perseus
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Together this suggests that the perturbation in the structure of the RNA polymerase up-
regulates certain stress-responses which may directly impact on the growth fitness of the
mutant (Gagneux et  al ., 2006).
Within the theme of a stress response, we observed that of 32 proteins (of the 48) genes
regulated by the DosR regulon (Kendall et  al ., 2004; Voskuil et  al ., 2004b) were significantly
over-abundant (p-value < 0.01) in the RIF-mono-resistant mutant (Table 7.2).  Previously it
has been shown that the DosR regulon is up-regulated under various stress conditions,
including hypoxia (Kendall, 2003) and its expression allows for long term survival under
aerobic conditions in a non-replicating state (Park, Guinn, et  al ., 2003).  Bartek and
colleagues showed that the DosR regulon in itself did not play an active role in M.
t ubercul osi s survival but suggested that the induction of a metabolically dormant-like state
could allow antibiotic tolerance (Bartek et  al ., 2009).  Together this suggests that the
perturbation in the structure of the RNA polymerase up-regulates certain stress-responses
which may directly impact on the growth state of the RIF-mono-resistant mutant which may
make it more resilient to antibiotic treatment (Louw et  al ., 2011). Furthermore, the observed
change in gene expression may explain the fitness cost associated with the evolution of RIF
resistance (Gagneux et  al ., 2006).
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Table 7.2: Significantly abundant proteins regulated by DosR regulon in RIF-mono-resistant mutant
Rv number Gene name Function Functional category P-value* Fold change$
Rv0080 - Unknown F10 0.03 2.9
Rv0081 - Involved in transcriptional mechanism F9 0.001 3.89
Rv0569 - Unknown F10 8.25E-5 3.06
Rv0570 N rd Z Involved in DNA replication pathway F2 3.05E-5 4.43
Rv0571 - Phosphoribosyl transferase
domain protein
F10 3.88E-4 2.55
Rv0574 Ca p A Capsule biosynthesis protein F10 0.08 4.79
Rv1736 N a rX Involved in nitrate reduction and
persistence in the host
F7 7.10E-5 6.54
Rv1737 n a rK2 Involved in excretion of nitrate F3 0.011 3.02
Rv1738 - Unknown F10 1.05E-6 11.2
Rv1813 - Possible membrane protein F10 0.007 20.61
Rv2004 - Unknown F10 1.54E-6 4.50
Rv2005 - Universal stress protein F0 2.55E-6 4.09
Rv2006 o tsB 1 Trehalose biosynthesis F0 3.05E-5 3.45
Rv2007 F d x A Involved in electron transfer F7 6.93E-6 6.58
Rv2028c - Universal stress protein F0 4.37E-6 8.18
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Rv2029 P fk B Involved in glycolysis F7 1.49E-4 6.19
Rv2030 - Erythromycin esterase homolog F10 2.52E-6 6.72
Rv2031 a c r,  h sp X Universal stress protein F0 4.04E-4 2.23
Rv2032 A c g Dinucleotide-utilizing enzyme F10 1.44E-7 3.13
Rv2623 TB 3 1 . 7 Universal stress protein F0 1.41E-5 3.50
Rv2624 - Universal stress protein F0 2.75E-5 4.08
Rv2625 - Probable conserved transmembrane
alanine and leucine rich protein
F3 2.86E-4 5.34
Rv2626 h rp 1 CBS domain protein F10 1.93E-4 2.64
Rv2627 D o sT Unknown F10 1.7E-6 3.21
Rv2629 P fk B Unknown F10 1.41E-4 2.33
Rv2630 - Archease F10 0.017 3.57
Rv3127 - Involved in lipid metabolism F10 3.88E-6 3.33
Rv3130c tg s1 Involved in synthesis of triacycglycerol F1 5.18E-7 3.85
Rv3131 - Unknown F10 4.72E-6 4.57
Rv3132 D o sS Regulatory protein F9 0.011 2.25
Rv3133 D o sR Regulatory protein F9 9.87E-5 3.84
Rv3134 - Universal stress protein F0 0.011 3.78
*Calculated using average iBAQ intensities
$Calculated using Perseus
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In a recent metabolomics study of two rpoB mutants, it was shown that the S531L mutant had
an advantage for using alternative energy sources in the form of fatty acids and cell wall
lipids.  Furthermore they also demonstrated that the rpoB mutation contributed to an altered
fatty acid metabolism (Du Preez and Loots, 2012).  We identified 39 of the protein products
of the genes involved in fatty acid biosynthesis listed by Takayama et  al . (Takayama et  al .,
2005).  However, only twelve of these proteins were significantly (p-value <0.05) over-
abundance in the RIF-mono-resistant strain (Table 7.3).  Interestingly, the IrtB protein was 58
times more abundant in RIF-mono-resistant strain.  This protein together with IrtA are also
required for growth in iron deficient conditions (Rodriguez and Smith, 2006).  It is predicted
that these proteins form an ABC transporter involved in iron sequestration (Rodriguez and
Smith, 2006).  No function has been associated with drug resistance.
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Table 7.3: Over-abundant (p-value < 0.05) in the RIF-mono-resistant strain proteins involved in the anabolic pathway of fatty acid metabolism of M. tuberculosis
Rv number Gene name Protein function P-value$ Fold Change*
Rv2243 fa d D Catlaysis malonyl-CoA-ACP transacylase activity 0.048 1.3
Rv2244 a c p M Fatty acid biosynthesis 0.006 1.2
Rv0533 fa b H Fatty acid biosynthesis 0.049 1.3
Rv1142c e c h A 1 0 Oxidise fatty acids 0.001 2.1
Rv1141c e c h A 1 1 Oxidise fatty acids 0.001 1.7
Rv1484 in h A Mycolic acid biosynthesis 0.004 1.3
Rv0644c mma A 2 Mycolic acid modification 0.007 1.2
Rv0643 mma A 3 Mycolic acids modification 0.007 1.3
Rv3400 - Probably involved in cellular metabolism 0.006 1.4
Rv2006 o tsB 1 Involved in trehalose biosynthesis 3.05E-5 3.5
Rv1349 irtB Involved in iron homeostasis 0.043 58
Rv1747 - Involved in active transport of lipooligosaccharide across membrane 2.44E-4 1.7
*Calculated according to average intensities (iBAQ)
$ Calculated using Perseus
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In summary, this is the first comprehensive analysis of the effect of the rpoB mutation on the
proteome of a RIF-mono-resistant mutant strain containing a S531L mutation.  Based on the
over-representation of 32 proteins in the DosR regulon, the proteome analysis presented in
this study suggests that the rpoB mutation allows for the bacteria to enter into a metabolically
altered state.  Furthermore, we identified over-represented proteins, vapC32, moaE2, rsfB and
aphC in the RIF-mono-resistant mutant that has previously been shown to be over-expressed
under various stress conditions.  These findings support a previous studies that the DosR
regulon may be important for bacteria to tolerate exposure to antibiotics (Bartek et  al ., 2009).
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CHAPTER 8
The label-free quantification of the proteome of a multi-drug resistant
M. tuberculosis strain before and after exposure to rifampicin
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8.1. Aim:
In this study we aimed to determine the influence of RIF on the proteome of a multi-drug
resistant (MDR) M.  t ube rcul osi s strain using a quantitative proteomics approach.  This study
aimed to build on the previous findings which showed that RIF induced an up-regulation of
certain efflux and transporter genes in RIF resistant M. t ubercul os i s isolates.  We
hypothesized that RIF induced a stress response in these strains which in turn lead to the
activation of efflux and transporter genes which would regulate the intracellular
concentration of RIF.  For this study we used an LC/MS/MS (LTQ-Orbitrap-Velos) approach
and analyzed the MS data with MaxQuant label-free proteomics software to quantify whole
cell lysate proteins extracted from an MDR M. tubercul osi s isolate (Louw et  al ., 2011) with
and without exposure to RIF for 24 hours.
8.2. Results and discussion:
8.2.1. Label-free quantification of the MDR M. tuberculosis proteome with and without
24 hours exposure to 2 µg/ml RIF
To identify the difference in abundance of proteins between the RIF exposed and unexposed
MDR M. t ubercul osi s cultures, the whole cell lysate proteins were analysed using the gel-LC-
MS/MS approach as described in figure 8.1. Label-free quantification of the proteins was
done using the MaxQuant software package; we compared the levels of protein abundance
between the RIF exposed and unexposed MDR M. t ubercul osi s isolate as described in
Chapter 3. A total of 90 LC/MS/MS files were analysed from 3 replicates of each growth
condition.
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Figure 8.1: Workflow for the analysis of the MDR M. tuberculosis isolate with and without exposure to
the critical concentration of RIF (2 µg/ml)
In our comparative analysis we used the intensity based absolute quantification (iBAQ)
algorithm, which normalizes the summed peptide intensities by the number of the theoretical
peptides of the protein (described in Chapter 5).  Using this approach we identified a total of
2044 proteins that were present under both growth conditions. Of these, 1553 (76%) proteins
were present in equal abundance. Figure 8.2 demonstrates a volcano plot of the average
iBAQ ratio of proteins extracted from the exposed and unexposed MDR M. t ubercul osi s
isolate as a function of the t-test p-values.
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Figure 8.2: Volcano plot of the RIF exposed/unexposed M. tuberculosis. Average iBAQ ratio as a function
of the t-test p-values. Green spots represent the differentially abundant proteins of unexposed MDR M.
tu b e rc u lo sis isolate; red spots represent the differentially abundant of RIF exposed MDR M.  tu b e rc u lo sis
isolate. Grey spots represent proteins in equal abundance
Over-represented proteins in exposed and unexposed MDR M. tuberculosis isolates
Perseus software (unpublished) in combination with the t-test (FDR threshold set to a P - val ue
of 0.01 - calculated from the normalized iBAQ intensities) were used to determine the
proteins that were significantly over-represented in either exposed and unexposed MDR M.
t ubercul osi s isolate (as described in Chapter 5).  We showed that the abundance of 502
proteins was significantly decreased on exposure to RIF, while the abundance of 44 proteins
was significantly increased under these conditions.  Proteins with a decreased abundance
could be grouped into 7 functional categories according to Tuberculist (figure 8.3).
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Figure 8.3: Functional categorisation of differentially abundant proteins in MDR M. tuberculosis isolate
with and without exposure to RIF. Abundant proteins represented as % of the identified proteins divided by
the total number of proteins characterised according to Tuberculist. Asterisks represent statistical significance
using the z-test ( p <0.05).
This result suggested that RIF induces a rapid decrease in the abundance of a subset of the
proteins involved virulence, detoxification and adaptation (functional category 0),
information pathways (functional category 2), cell wall and cell wall processes (functional
category 3), intermediary metabolism and respiration (functional category 7), regulatory
proteins (functional category 9) and conserved hypothetical proteins (functional category 10).
Conversely, RIF exposure did not influence the abundance of proteins involved in stable
RNAs (functional categories 4), insertion sequences and phages (functional categories 5) and
PE/PPE (functional categories 6).
Results obtained in this study indicate that the presence of RIF continues to cause an
environmental stress on the RIF resistant MDR M. t ubercul osi s isolate, leading to the
reduction in several biological processes.  This differs from the dogma which suggests that
RIF resistance is simply a reflection of the change in the binding constant between RIF and
the RNA polymerase due to mutation in the rpoB gene (Campbell et  al ., 2001).
More recently it has been suggested that prolonged exposure may contribute to the evolution
and adaptation of M.  t ubercul osi s whereby it could acquire putative compensatory
mechanisms to survive (Gagneux et  al ., 2006).  The putative compensatory mechanisms
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could include the production of enzymes that could alter or inactivate the antibiotic, decrease
the cell wall permeability or alternative mechanisms such as efflux pumps (Singh et  al .,
2011).  Previous studies have demonstrated the association between efflux pump activation
and RIF resistance where a number of these efflux pumps ( Rv1258c , Rv1410c , Rv1819c , and
Rv2136c ) were up-regulated in the presence of RIF (Wilson et  al ., 1999; Siddiqi et  al ., 2004;
Geiman et  al ., 2006; Jiang et  al ., 2008; Louw et  al ., 2009).  To test this hypothesis we
interrogated the proteomic data to determine if these efflux pumps were over-represented in
the RIF exposed MDR M . t ubercul osi s isolate (Table 8.1).
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Table 8.1: Efflux pumps identified in the current study which were previously shown to be up-regulated in the presence of RIF.
Rv number Gene name Fold change (RIF exposed vs. unexposed)* P-value$
Rv2989 - 1.5 0.155
Rv0342 in iA 0.2 0.005
Rv1819 b a c A 0.3 0.341
Rv1463 - 0.7 0.224
Rv1747 - 0.13 0.006
Rv2994 - 0.02 0.006
Rv3806 u b iA 0.1 0.005
Rv3679 - 0.4 0.043
Rv2942 mmp L7 0.3 0.027
Rv2688 - 0.3 0.172
Rv2936 d rrA 0.2 0.001
Rv2937 d rrB 1.41 0.579
* Calculated ratio based on average iBAQ intensities
$ Calculated in Perseus
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Only 12 of the previously described efflux pumps were identified in this study (Cole et  al .,
1998; Gupta et  al ., 2010; Louw et al ., 2011).  However significant increase in their
abundance in response to RIF could not be demonstrated.  Similarly, our analysis could not
demonstrate an increase in the abundance in the ATP synthase subunits in response to RIF.
This differs from a Quantitative Real-Time PCR (qRT-PCR) study which demonstrated that
the ATP synthase operon was up-regulated in response to RIF (unpublished data, M de Vos,
PhD, 2012).  This may be explained by the fact that a direct comparison cannot always be
made between the transcriptome and proteome due to methodological limitations.  Protein
sequence coverage of membrane proteins may be limited due to their inherent physical
properties which include the insolubility as well as the absence of charged residues in the
membrane spanning domains.  This limitation can be partially overcome by the inclusion of
detergents (such as Triton X-114) in the extraction protocol to increase the solubility of
membrane proteins (Målen et  al ., 2008).  However, in the current study we did not employ
this strategy which leads to the under-representation of cell wall and lipid membrane proteins
(48%) vs . proteins involved in information pathways (84%).  Furthermore, PTMs could also
pose a challenge to the detection of these membrane associated proteins as both the efflux
pumps and ATP Synthase may exist in a phosphorylated state (Barrera and Robinson, 2011).
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Table 8.2: Differentially abundant proteins with a fold change greater than 10 in the RIF exposed MDR- M. tuberculosis isolate
Rv number Gene name Corresponding PATRIC annotation Protein function
Functional
category
P-value* Fold change$
Rv3555c - VBIMycTub87468_2314 DNA binding F10 0.000 1078.27
Rv0531 - VBIMycTub87468_0589 Possible transmembrane protein F3 0.009 274.68
Rv3919c g id VBIMycTub87468_4369 Probable glucose-inhibited division protein B F3 0.000 175.04
Rv0298 y d c D VBIMycTub87468_0330 Programmed cell death toxin F10 0.004 64.51
Rv2325c - VBIMycTub87468_2595
Transmembrane component of energizing
module of ECF transporters in Mycobacteria
F10 0.000 51.15
Rv0598c v a p C2 7 VBIMycTub87468_0664 Toxin 1, PIN domain F0 0.000 29.46
Rv3576 lp p H VBIMycTub87468_3993 Non-specific serine/threonine protein kinase F3 0.001 23.09
Rv1959c p a rE 1 VBIMycTub87468_2187 Plasmid stabilization protein F0 0.000 19.55
Rv3817 a p h VBIMycTub87468_4250 Phosphotransferase F7 0.002 17.38
Rv3203 lip V VBIMycTub87468_3582 Possible lipase F7 0.005 15.08
Rv2303c - VBIMycTub87468_2566 probable antibiotic resistance protein F0 0.006 14.39
Rv0826 - VBIMycTub87468_0921 Hypothetical protein F10 0.001 13.63
Rv0201c - VBIMycTub87468_0228 Hypothetical protein F10 0.000 11.40
* Calculated in Perseus
$ Calculated ratio based on average iBAQ intensities
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Our comparative analysis showed that 13 proteins were over-abundant (p-value < 0.01
and average iBAQ ratio >10 fold) in the RIF exposed MDR M. t ubercul osi s isolate
(Table 8.2.). Four of these proteins (Rv3555c, Rv2325c, Rv0826 and Rv0201c) have
been assigned as conserved hypothetical category with no known function. Rv3817
and Rv3203 were involved in intermediary metabolism and respiration.  The
phosphotransferase Rv3817 is involved in the lipopolysaccharide production which is
a key component of the outer membrane (Brennan, 2003).  However, its role in drug
resistance has not been investigated, although changes in the lipopolysaccharide
structure of the cell envelope have been shown to cause changes in resistance to a
variety of antibiotics (McKay et  al ., 2003). Rv3203 (LipV) is one of the 21 genes in
the M. t ub ercul osi s genome that encode for lipases/esterases (Deb et  al ., 2006).  The
authors hypothesised that lipases release fatty acids from triacylglycerol (TG) stores
when the bacilli are under nutrient stress.  Lipases/esterases hydrolyse TG which
accumulates following various stress conditions in M. t ubercul osi s (Daniel J, et  al .
2004; Sirakova TD et  al . 2006; Natalie J. Garton et. al., 2008).  Hydrolysis of TG by
lipases/esterases provides fatty acids as a carbon source which in turn contributes to
an alteration of the mycobacterial cell envelope (Garton et. al. 2008).
Three cell wall proteins (Rv0531 essential, Rv3576, and Rv3919c (Gid)) were
significantly over-abundant in the RIF exposed MDR M. t ubercul osi s isolate (Table
8.2).  However, their functions have not been described.  Analysis of the protein
sequences using the online transmembrane prediction tool that uses the Hidden
Markov Model (TMHMM Server v. 2.0) predicted that Rv0531 has two
transmembrane domains while Rv3576 only had one transmembrane domain.  The
glucose-inhibited division protein (Gid), also known as GidB, was not predicted to
have a transmembrane domain but has been associated with low-level streptomycin
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resistance in M.  t ubercul osi s (Spies et  al ., 2011). This is supported by a recent study
that demonstrated that streptomycin resistant isolates contained a point mutation in the
E92D of the gi dB gene (Via et  al ., 2010).
Three proteins (Rv2303, Rv0598 and Rv1959) involved in virulence, detoxification
and adaptation were significantly over-abundant in the RIF exposed MDR M.
t ubercul osi s isolate.  Rv2303 is thought to possibly be involved in antibiotic
resistance (Gillespie et  al ., 2011).  Rv0598 (VapC27) and Rv1959 (ParE1) were
previously identified in the cell envelope of M. t ubercul osi s H37Rv after membrane
enrichment withTritonX-114 (Målen et  al ., 2008).  Both of these proteins are thought
to be toxins and part of the toxin-antitoxin system (Jiang et  al ., 2002; Ramage et  al .,
2009).  Toxin-antitoxin (TA) systems are the most common mechanisms involved in
bacterial programmed cell death (PCD).  Similarly, the hypothetical protein, Rv0298,
when searched against the bacterial bioinformatics resource centre, PATRIC
(PathoSystems Resources Integration Centre) (Snyder et  al ., 2007; Gillespie et  al .,
2011) the corresponding locus tag (VBIMycTub87468_0330) lists this gene to encode
for an antitoxin (YdcD) which is proposed to be involved in PCD.  The mass
spectrometer failed to detect the toxins Rv1246c (RelE) and Rv1495 (MazF4), in the
unexposed MDR M. t ubercul osi s isolate.  These were however detected in the
exposed MDR isolate.  PCD in prokaryotes allows bacteria to survive under
environmental stresses such as nutrient deprivation, antibiotics exposure, hypoxia in
the macrophages, etc. (Dahl et  al ., 2003).  It has been hypothesised TA systems may
be important for changing growth rate, inducing long term dormancy and in
generating bacilli that can survive multidrug chemotherapy (Dahl et  a l ., 2003; Beste
et  al ., 2009; Han et  al ., 2010; Frampton et  al ., 2012).  The TA system are organised in
operons composed of two genes in which the first open reading frame (ORF) encodes
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a labile antitoxin that combines with and neutralizes a stable regulatory toxin encoded
by the second ORF (Hayes, 2003; Gerdes et  al . , 2005; Singh et  al ., 2010).  The M.
t ubercul osi s H37Rv and CDC1551 genome encodes for 88 putative TA systems
(Arcus et  al ., 2005; Pandey and Gerdes, 2005; Ramage et  al ., 2009; Frampton et  al .,
2012) clearly suggesting the importance of these systems in the physiology of M.
t ubercul osi s .  TA systems are associated with translational maintenance, DNA
replication and bacterial persistence (Hayes, 2003).  These TA system pairs also
forms part of the dormancy regulon (DosR) (Florczyk et  al ., 2001; Shi et  al ., 2003)
and have been shown to be induced after exposure to vancomycin (Provvedi et  al .,
2009).  This suggests that they may play an important role in the regulation if
mycobacterial growth in response to diverse stress conditions and also could act as
cell cycle arrest factors that induce the mycobacterial cell to enter a state of dormancy
to protect it against environmental stress conditions.  Furthermore, RelE and MazF are
regulators of translation by cleavage of  mRNA to block translation (Christensen et
al ., 2003).  Both RelE and MazF cleave mRNA: RelE requires the ribosome for RNA
cleavage while MazF does not (Christensen et  al ., 2003).  Accordingly, it is suggested
that toxins, RelE and MazF function in the quality control of gene expression.  The
toxins, RelE and MazF, are the best studied TA toxins in E. col i (Korch et  al ., 2009).
Both RelE and MazF induced reversible dormancy in E. col i and M. t ubercul osi s
(Korch and Hill, 2006; Korch et  al ., 2009).  However, toxin-induced growth arrest
was reversed upon the expression of each toxin’s cognate antitoxin (Korch et  al .,
2009).  Interestingly, over-expression of RelE in M. t ubercul osi s increased bacterial
survival in the presence of RIF (Singh et  al ., 2010).  Similar studies have not been
done for MazF in M.  t ubercul osi s , however, exposure to RIF induced the expression
of m azF in E. col i (Kolodkin-Gal et  al ., 2008).
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In summary, this is the first comprehensive analysis of the effect of RIF on the
proteome of a RIF resistant MDR M. t uber cul osi s isolate.  The analysis highlights two
physiological events; 1) remodeling of the cell envelope and 2) initiation of a
dormant/persistent growth phase which is associated with a significant decrease in the
abundance of 25% of the proteome. Together this suggests that RIF continues to
influence the biology of M. t ubercul os i s despite the presence of an rpo B mutation.
These findings support a recent study which showed that RIF exposure induced the
MDR M. t ubercul osi s isolate to become less refractive to other anti-TB drugs (i.e.
ofloxacin) (Louw et  al ., 2011).
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CHAPTER 9
Conclusion and Prospective studies
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Since the advent of whole genome sequences of laboratory strain (H37Rv) and the
first M . t ubercul osi s clinical isolate (CDC1551) a new era has dawned in the field of
TB research. Subsequently, an ever increasing number of genomes from clinical
isolates are sequenced with the view to correlate mutation to phenotype. Despite
these advances, our understanding of the mechanisms of M. t ubercul osi s pathogenesis
remains limted.  This can in part be ascribed to the fact that the field of proteomics
has lagged behind the genomics era. Furthermore, most proteome studies are focused
on identifying individual novel drug targets.  However, with the advancement in mass
spectrometry technology it is clearly evident that the field of proteomics will enhance
our understanding of the physiology of M. t ubercul osi s .  Ideally, genomics,
proteomics, transcriptomics, lipidomics and metabolomics platforms need to be
combined to provide a systems biology approach to unravel the biology of M.
t ubercul osi s .
The studies described in this thesis were designed to use the latest state of the art high
throughput mass spectrometry to identify proteomic differences to develop hypotheses
to explain the mechanisms underlying varying levels of virulence and drug resistance.
This is the first study to characterise the proteome of members of the M. t ubercul osi s
Beijing lineage which have been linked to outbreaks and drug resistance.
Using a label-free proteomics approach we were the first to characterise the
proteomes of two closely related hypo- and hyper-virulent clinical M.t ubercul osi s
strains with different levels of virulence (Chapter 4) (de Souza et  al ., 2010). The
resolution of this analysis was further enhance when using a more advanced mass
spectrometer with an increased sensitivity. Through this analysis it was possible to
identify an additional 1146 proteins in whole cell lysate (Chapter 5).  This represents
the highest number of M. t ub ercul osi s proteins identified to date within a single
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experiment.  This comparative analysis highlighted numerous factors that could alter
metabolic pathways which allowed the hyper-virulent strain to rapidly replicate within
the host and cause pathology as well as factors which contributed to the attenuation of
virulence in the hypo-virulent and non- transmitting M. t ubercul osi s strain. For
example, we showed an increased abundance of proteins involved in biosynthesis
pathways of several carbon sources, i.e. lipid metabolism, central carbon metabolism
(glycolysis/gluconeogenesis and TCA cycle), and amino acid biosynthesis that can be
utilised by the mycobacterium bacilli as a source of energy for long-term survival
In chapter 6 we identified novel phosphorylation sites as well as confirming
previously described phosphorylation sites.  Furthermore, for the first time we were
able to demonstrate tyrosine phosphorylation in mycobacteria. This work was
complemented with a review (Chapter 2) describing the state of our knowledge in the
field of phosphoproteomics in M. t ubercul osi s .
In chapter 7 we present the first comprehensive analysis of the effect of i n vi vo
evolution of RIF resistance on the proteome of a RIF-mono-resistant mutant strain
containing a S531L mutation.  We identified the presence of over-abundant proteins
which could provide novel insight into potential compensatory mechanisms that the
bacillus uses to reduce susceptibility to anti-TB drugs. Our findings show that
proteins involved in a stress response may relate to altered physiology enabling the
pathogen to tolerate and persist when exposed to anti-TB drugs. These findings
support a previous studies that showed that the DosR regulon may be important for
bacteria to tolerate exposure to antibiotics (Bartek et  al ., 2009).
Furthermore we also present the first comprehensive analysis of the effect of RIF on
the proteome of a RIF resistant MDR M. t ubercul osi s isolate (Chapter 8).  Our
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analysis suggests that RIF continues to influence the biology of M.  t ubercul osi s
despite the presence of an rpoB mutation.  We observed a significant decrease in the
abundance of 25% of the proteome suggesting exposure to RIF causes an alteration in
the cell envelope composition and further leads to the bacterium to survive in a
metabolically dormant/ persistent growth phase. Our findings also suggest that the
presence of RIF may further induce a reversible persistent growth state which is
refractive to RIF.
In conclusion, in this study we were able to use a novel proteomic approach to
characterise the proteomes of M. t ubercul osi s strains which demonstrate different
physiological phenotypes, including varying levels of virulence and drug resistance.
Our results illustrate the full potential of a proteomic approach to select promising
candidate molecules and genes for further characterization using the tools of
molecular biology.
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Prospective studies
The results presented in this thesis provides a resource of clinical importance for
further investigation into the significance of the candidate proteins involved in
fundamental biological processes that broaden our knowledge of M. t ubercul osi s
pathogenesis.
1. Identified candidate phosphorylated proteins can be further analysed by
specialised bioinformatics tools to identify novel substrates that could be
implicated in virulence.
2. The whole phosphorylome could be analysed to determine the involvement of
a group of phosphorylated proteins in a cascade of events in a network leading
to a physiological change, i.e. levels of virulence and drug resistance.
3. Furthermore phosphorylated proteins can be assessed by determining the level
of expression of a potential candidate’s influence on other proteins and on the
phenotype of a particular strain of M. t ubercul osi s .
4. Candidate proteins identified in proteome studies of drug resistant isolates can
be futher analysed to determine and provide insight into other potential
compensatory mechanisms the M. t ubercul osi s bacilli in response to the
S531L rpoB mutation as well as other mutations.
5. Since we have identified one of the potential compensatory mechanism, such
as the toxin-antitoxin system, that is involved in the physiological and
biological alteration M.  t ubercul osi s in response to RIF exposure we can
assess how these bacilli respond within the host.
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6. The ultimate validation would be to challenge these hypotheses created in this
study by the proteome analysis of the M. t ubercu l osi s strains in macrophages.
This would potentially give more insight on how these candidate proteins
identified in this current study is influenced in the host environment and in
turn provide more clinical significance of these phenotypes.
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